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Footnotes
a Rmerge = ∑ hkl  ∑ i | Ii(hkl) - I(hkl) | / ∑ hkl  ∑ i  Ii(hkl), where index hkl sums over all reflections 
                 and i sums over all equivalent and symmetry-related reflections (Stout & Jensen, 
                 1968).
b Rrim is the redundancy-independent merging  R-factor (Weiss & Hilgenfeld, 1997), which 
is identical to Rmeas of Diederichs and Karplus (1997).  Rrim = ∑ hkl {N / (N – 1)}1/2  ∑ i|  
           Ii(hkl) - I(hkl) | / ∑ hkl  ∑ i  Ii(hkl), with N being the number of times a given reflection      
           has been observed.
c Rpim is the precision-indicating merging R-factor (Weiss & Hilgenfeld, 1997). Rpim = ∑ hkl 
           {1 / (N – 1)}1/2  ∑ i | Ii(hkl) - I(hkl) | / ∑ hkl  ∑ i  Ii(hkl).
d R     = ∑ hkl || Fobs | - k | Fcalc ||  /  ∑ hkl | Fobs | , where k is a scale factor.
e Rfree = ∑ hkl⊂T || Fobs | - k | Fcalc ||  /  ∑ hkl⊂T | Fobs | , where hkl⊂T indicates all reflections 
             belonging to a test set T of unique reflections. The refinement is carried out 
 without reflections in the test set, making the Rfree value an unbiased indicator 
 of the refinement process.
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Zusammenfassung
Lysosomale Proteinasen werden in der Zelle als Vorläufermoleküle mit einer N-terminalen 
Prodomäne (Propeptid) synthetisiert, die die katalytische Aktivität des Enzyms blockiert. Am 
Beispiel  des  menschlichen  Cathepsin  S  konnte  gezeigt  werden,  dass  diese  Propeptide 
darüberhinaus als Faltungskatalysator für die Enzymdomänen agieren. Diese Funktionen der 
L-ähnlichen  Cathepsin  Propeptide,  zu  denen  auch  Cathepsin  S  gehört,  sind  mit  der 
Ausbildung einer Raumstruktur dieser Propeptide verbunden, deren strukturelle Besonderheit 
–  die  terminale  Mini-Domäne  –  auf  diese  Unterfamilie  beschränkt  ist.  Diese  Vermutung 
wurde sowohl  in-vitro durch Faltung und Inhibition von Cathepsin S in Gegenwart seines 
Propeptids und einiger Propeptidmutanten mit ausgetauschten konservierten Aminosäuren, als 
auch  in-vivo mit  gleichermassen  mutierten  Zymogenen  erhärtet.  Darüberhinaus  deuteten 
spektroskopische  Untersuchungen  eine  von  den  Enzymdomänen  unabhängige  Ausbildung 
einer  tertiären Struktur  des Propeptids an.  Die Struktur des isolierten Propeptids ist  nicht 
bekannt.  Bislang galt dies auch für die Struktur des Zymogens (Procathepsin S), allerdings 
deuteten  Vergleiche  der  Proteinsequenzen  innerhalb  der  L-ähnlichen  Cathepsine  auf  eine 
hohe  Übereinstimmung  der  Procathepsin  S  Struktur  mit  anderen  Vertretern  dieser 
Unterfamilie hin. Das Cathepsin S-Propeptid zeigte als Inhibitor bislang keine signifikante 
Selektivität  gegenüber  verwändten  L-ähnlichen  Cathepsinen.  Umgekehrt  gilt  dies  nur 
eingeschränkt.  So  ist  beispielsweise  die  Hemmung  des  Enzyms  durch  das  Cathepsin  L- 
Propeptid  deutlich  vermindert,  was  auf  Cathepsin  S  spezifische  Interaktionen  zwischen 
Propeptid und Enzym hinweist.  
Zum besseren Verständnis der  Interaktionen zwischen Cathepsin S und seinem Propeptid 
bezüglich  Faltung,  Inhibition  und  Selektivität  war  die  Aufklärung  der  Raumstruktur  des 
Zymogens  unumgänglich.  Darüberhinaus  sollte  der  Frage  nachgegangen  werden,  welche 
Konsequenzen die eingeführten Mutationen auf die Propeptidstruktur und seine Verankerung 
an die Enzymoberfläche haben könnten. Desweiteren wurde der Versuch unternommen, die 
unbekannte  Struktur  des  isolierten Propeptids  aufzuklären,  um sie  anschliessend mit  dem 
equivalenten  Element  des  Zymogens  zum  besseren  Verständnis  des  Faltungsprozesses 
vergleichen zu können. 
                                                                                                                                                   1
-----------------------------------------------------------------------------------------------------Zusammenfassung
Im Rahmen dieser Arbeit konnte die Struktur einer kristallisierten menschlichen Procathepsin 
S  Mutante  (Cys25→Ala),  in  der  das  Cystein  im  aktiven  Zentrum  zur  Herstellung  einer 
inaktiven Mutante ausgetauscht wurde, bei einer Auflösung von 2.1 Å aufgeklärt werden. Im 
Vergleich  mit  anderen  Proenzymen  der  L-ähnlichen  Cathepsinen  konnte  innerhalb  der 
Propeptidstruktur eine verlagerte Position der dritten Helix (α3p), die oberhalb des aktiven 
Zentrums  die  Substratbindungstasche  S´1  abdeckt,  festgestellt  werden.  Die  veränderte 
Stellung dieser Helix wird durch eine Cathepsin S spezifische Wechselwirkung zwischen dem 
konservierten  Met83  im  Loop  oberhalb  dieser  Helix  und  Phe146  des  PBL  (prosegment 
binding loop) des Enzyms beeinflusst.  Phe146 ist  in dieser Position einzigartig  in  der L-
ähnlichen  Cathepsin  Unterfamilie  und  hat  neben  der  in  nächster  Nähe  befindlichen 
Aminosäure Arg141 einen entscheidenen Einfluss auf die Selektivität für andere Cathepsin-
Propeptide. Darüberhinaus scheint Phe146 an der Ausbildung der Substratbindungstasche S´1 
beteiligt  zu sein.  Im C-terminalen  Bereich  des  Propeptids  konnte  ebenfalls  eine  derartige 
Wechselwirkung zwischen dem Propeptid über Pro98 und der Enzymoberfläche über Phe70 
festgestellt  werden.  Der  aromatische  Seitenkettenrest  von  Phe70  wurde  bisher  der  S3 
Bindungstasche  zugeordnet.  Aus  der  Wechselwirkung  mit  dem  Propeptid  lässt  sich  eine 
mögliche Beteiligung an der Ausformung von S2 ableiten, welche für Kollagen als Substrat 
von Bedeutung ist. 
 
Für die Stabilisierung der Propeptidstruktur und seiner Verankerung an der Enzymoberfläche 
zeichnen sich die drei Tryptophane 28, 31 und 52 aus, die durch ihre Stellung zueinander 
(Trp28 und Trp31 von Helix α1p; Trp52 von Helix α2p) einen hydrophoben Kern bilden. Die 
beiden  Seitenkettenreste  der  Aminosäuren  Val59  und  Asn63  von  Helix  α2p  tragen  zur 
Verankerung  des  Propeptids  an  der  Oberfläche  des  Enzyms  über  den  PBL  (prosegment 
binding  loop)  bei.  Die  Proenzymstruktur  zeigt,  dass  der  jeweilige  Austausch  dieser 
Aminosäuren durch Alanine zum Verlust bzw. zur Reduktion von Kontaktflächen zwischen 
den beiden o.g. Helices und zwischen Propeptid- und Enzymoberfläche führt. In allen Fällen 
führte  dies  zu  einer  signifikanten  Abnahme  der  Hemm-  und  Faltungskompetenz  der 
jeweiligen Propeptidmutanten. Drei der mutierten Aminosäuren (Trp52, Val59 und Asn63) 
gehören zum konservierten ER(F/W)N(I/V)N Motiv. In Verbindung mit Trp28 und Trp31, 
die mit Trp52 den hydrophoben Kern bilden, handelt es sich hierbei um ein für das Propeptid 
funktionell bedeutsames Motif für die Faltung und Inhibition.
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Das  pH-Optimum  von  Cathepsin  S  liegt  im  sauren  Bereich.  Im  Gegensatz  zu  anderen 
verwandten Cathepsinen ist  Cathepsin S dennoch über ein breites pH-Spektrum aktiv und 
erweist  sich  selbst  unter  basischen  Bedingungen  als  äusserst  stabil.  Dies  kann  mit  dem 
elektrostatischen  Potential  des  Enzyms  erklärt  werden,  das,  im  Gegensatz  zu  den  unter 
basischen Bedingungen sehr instabilen verwandten Enzymen, mehr neutralen Charakter hat. 
Dies trifft vor allem für das aktive Zentrum und seine unmittelbare Umgebung zu.
Als eine grosse Herausforderung stellte sich die Kristallisation des Cathepsin S Propeptids 
heraus.  Die  geringe  Löslichkeit  dieses  Proteins  im  gefalteten  Zustand  erforderte  die 
Entwicklung  einer  neuen  Kristallisationsstrategie,  die  aus  einer  Kombination  der 
konventionellen  Methode der  Dampfdruckdiffusion und einem durch  einen  schnellen  pH-
Wechsel  evozierten  Faltungsschritt  der  denaturierten  Propeptidmoleküle  besteht.  Diese 
Strategie könnte in Zukunft auch für die Kristallisation von anderen Proteinen oder Peptiden 
mit ähnlichen Eigenschaften interessant sein. 
Auch wenn die Struktur des Cathepsin S Propeptids noch nicht gelöst werden konnte, kann 
seine Kristallisation als zusätzliches Indiz für eine tertiäre Struktur angesehen werden. Diese 
Struktur  sollte  sich  nur  unwesentlich  von  dem  equivalenten  Element  des  Proenzyms 
unterscheiden.  Die  Basis  für  eine  zukünftige  Aufklärung der  Propeptidstruktur  ist  gelegt. 
Zukünftige  Untersuchungen  an  kristallisierten  Komplexen  zwischen  Cathepsin  S  und 
Propeptid sollten weiterhelfen den Faltungsprozess und die darauf basierenden Interaktionen 
zwischen Propeptid und Enzym besser zu verstehen.
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1. Introduction
1.1 Cathepsin S: tissue distribution and function
Cathepsin  S  (EC  3.4.22.27)  is  a  highly  active  lysosomal  cysteine  proteinase  that  was 
originally  purified  from  bovine  lymph  nodes  (Turnsek  et  al.,  1975)  and  bovine  spleen 
(Kirschke et al., 1986). The enzyme is a papain-family (C1) (Rawlings & Barret, 1993, 1994) 
member of  the clan CA of cysteine peptidases (Kirschke  et al.,  1995),  which are  widely 
expressed throughout the animal and plant kingdoms and have also been identified in viruses 
and bacteria. The cathepsins, which belong to the superfamily of the papain-like proteinases, 
are located intracellulary in the lysosomal compartment and play an important role in protein 
degradation. Cathepsin S is found mainly in lymph nodes, spleen and macrophages, including 
rat brain glial cells, but is absent or expressed only at very low levels in kidney, liver, heart, 
pancreas,  ovary,  and  small  intestine  (Kirschke  et  al.,  1986,  1989,  Qian  et  al.,  1991, 
Petanceska  & Devi, L,  1992, Petanceska  et al., 1994, 1996).  The main occurrence of the 
enzyme in lymphatic tissue, especially in cells presenting antigens bound to MHC class II 
heterodimers, prompted speculation concerning a special function for cathepsin S in normal 
and diseased tissues. Cathepsin S is involved in the stepwise processing of the invariant chain 
li (Riese et al., 1996), thus liberating the binding groove for antigenic peptides to be presented 
by MHC class II proteins. Selective irreversible inhibition of cathepsin S resulted in a delayed 
immune response (Riese et al., 1998, Saegusa et al., 2002). Therefore, cathepsin S could be a 
target for treatment of immune-related disorders. Adenovirus mediated antisense gene transfer 
experiments  in  rats  proved a  further  physiological  role  of  cathepsin  S for  normal  retinal 
function (Lai et al., 2000). Cathepsin S has a strong elastin-degrading activity (Brömme et al., 
1996, Shi et al., 1992) suggesting a role in the progressive erosion of the elastic arterial walls 
during atherosclerosis.  A selective inhibitor of cathepsin S blocked approximately 80% of the 
elastolytic  activity  of  IL-1ß  or  IFN-γ activated  primary  cultures  of  smooth  muscle  cells 
(Sukhova et al., 1998). Furthermore, it shows collagenolytic activity (Kirschke et al., 1989). 
In  addition  to  a  decreased  processing  of  the  invariant  chain  li,  Nakagawa  et  al.  (1999) 
demonstrated a diminished collagen erosion in arthritic, cathepsin S deficient mice. Cathepsin 
S could be immunohistochemically localized in cortical neurons and glial cells in brains of 
patients with Alzheimer’s disease (Munger et al., 1995). In addition, a high concentration of 
cathepsin  S  in  rat  brain  glial  cells  (Petanceska  et  al.,  1994,  1996)  was  shown.  An 
overexpression of cathepsin S in HEK 293 cells led to an increased secretion of  β-amyloid 
fragments. Like cathepsin B, L, and H, cathepsin S has also been correlated with tumor       
4
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progression  (Kos  et  al.,  2000).  In  contrast  to  most  other  lysosomal  cysteine  peptidases, 
cathepsin S is stabile at neutral and even slightly alkaline pH (Kirschke et al., 1989). Neither 
the structural basis of this stability nor its possible functional importance have been elucidated 
up to now, although the X-ray structure of the enzyme has been published twice (McGrath et 
al., 1998; Turkenburg et al., 2002). For more information the reader is referred to the reviews 
by Turk et al. (2000) and Lecaille et al. (2003).
1.2 Synthesis, transport  and activation 
As most other peptidases, cathepsin S is synthesized as an inactive precursor containing an 
additional  N-terminal  domain,  the  so-called  propeptide  or  prodomain.  After  the 
cotranslational  transport  of  the  precursor  into  the  endoplasmatic  reticulum  (ER),  the 
propeptide is N-glycosylated at Asn104, a canonical glycosylation site with sequence Asn-X-
Ser/Thr.  The  precursor  is  transported  into  the  cis-Golgi  compartment,  where  the 
oligosaccharide chain is processed by a cleavage of sugar residues, and one or more terminal 
mannose  residues  are  phosphorylated  (Kornfeld  &  Kornfeld,  1985).  In  this  way,  the 
recognition signal for the membrane spanning mannose-6-phosphate receptors in the  trans-
Golgi system is created (Cantor et al., 1992), and the precursor is transported via the known 
mannose-6-phosphate-way  into  the  lysosomal  compartment  (von  Figura  & Hasilik,  1986, 
Griffiths  et al., 1988, Kornfeld & Mellman, 1989). In the lysosomes, the activation or so-
called  maturation  (processing)  to  the  active  enzyme  is  invoked  by  the  cleavage  of  the 
propeptide at acidic pH (Brown & Swank, 1983, Samarel et al., 1989, Delbruck et al., 1994). 
Beside this way, cathepsin S can be transported into the extracellular room via the secretory 
way.  Nissler  et al.  (1998, 2002) demonstrated a reuptake of cathepsin S into cells, and the 
transport of non-glycosylated proenzyme (procathepsin S) into the lysosomes suggesting an 
additional  sorting  motif  in  the  cathepsin  S  molecule  besides  the  mannose-6-phosphate 
residues.    
5
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1.3 Structure of cathepsin S
In 1992, human cathepsin S was cloned, and the sequence described by Shi et al. (1992) and 
Wiederanders et al. (1992). The precursor procathepsin S contains a propeptide of 114 amino 
acid residues, which include an N-terminal signal sequence of 16 amino acid residues. The 
domains  of  the  mature  enzyme  contain  217  amino  acid  residues.  At  DNA level  a  high 
homology was shown for mature cathepsin S to other members of the papain like family. This 
has  recently  been  confirmed  by  the  determination  of  a  cathepsin  S-inhibitor  complex 
(McGrath et al., 1998) as well as of an inactive cathepsin S Cys25→Ser mutant (Turkenburg 
et al., 2002) at structural level. As found for papain-like cysteine proteinases, cathepsin S 
consists of two domains, referred to as L (left) and R (right) domain (see Figure 4-20). The 
central helix, about 30 residues long, is the most prominent feature of the L-domain, whereas 
the fold of the R-domain is based on a  β-barrel motif. The two domains interact through a 
large planar interaction surface forming a ‘V’-shaped substrate-binding sites cleft with the 
three active site residues Cys25, His164, and Asn184. In the active form of the enzyme, the 
charged active site residue His164 forms an ion pair with Cys25 and Asn184. The proenzyme 
has a calculated molecular mass of 37,479 Da, and the active enzyme of 23,993 Da. 
1.4 The propeptide of cathepsin S
1.4.1 Primary structure and homology
At  DNA  level,  the  N-terminal  propeptide  of  cathepsin  S  is  highly  homologous  to  the 
propeptides of many other papain-family members, which are classified as cathepsin L-like 
endopeptidases  (Karrer  et  al.,  1993,  Kirschke  et  al.,  1989)  (see  Figure 1-2).  The  tertiary 
structure  of  two  zymogens  of  this  subfamily  has  already  been  elucidated,  namely 
procathepsins L (Coulombe et al., 1996) and K (Sivaraman et al., 1999; LaLonde et al., 1999) 
(see Figure 1-1). Their propeptide structure is similar: A mini-domain, the backbone of which 
is built by two crossed helices, α1p and α2p (suffix p stands for propeptide), anchores in the 
corresponding  binding  loop of  the  enzyme and directs  the  adjacent  extended part  of  the 
propeptides  in  a  non-productive  orientation  along  the  active  site  cleft  between  the  two 
domains of the mature enzyme. A third helix (α3p) covers the substrate binding sites (S´) 
above the active-site cleft. Thus, access of substrate proteins to the catalytic site is prevented. 
In the protein sequence of the cathepsin S propeptide, two highly conserved motifs are found, 
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which have previously been identified in the same propeptide regions of cathepsin L, K, and 
papain:  ER(F/W)N(V/I)N (Karrer  et  al.,  1993)  and  GNFD (Vernet  et  al.,  1995).  The 
conserved  residues  of  these  sequences  are  involved  in  salt  bridges  and  hydrogen  bonds 
contributing to the stabilization of the tertiary propeptide structure. Therefore, the packing of 
the helices α1 and α2 is determined by the interactions of three aromatic residues, in the case 
of procathepsin L and K three tryptophanes. These aromatic residues form a hydrophobic 
core. In the cathepsin S propeptide sequence, the three tryptophanes are located in the same 
positions as found in the propeptide regions of the enzymes mentioned above. The conserved 
character and position of the residues supports the idea, that the structure of the cathepsin S 
propeptide is similar to other L-like cathepsin propeptides (Maubach et al., 1997, Schilling et 
al.,2001).
 
A                                                                                 B
Figure 1-1 Structures of procathepsins L and K
Cartoon presentation of procathepsin L (picture A, PDB entry 1CS8, Coulombe et al., 1996) 
and K (picture B, PDB entry 1BY8, LaLonde et al., 1999). The enzyme domains are coloured 
in turquois, and the propeptides in red. Picture drawn with Molscript (Kraulis, 1991).
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1.4.2 The propeptide as inhibitor 
The inhibitory action of the propeptide was shown with recombinant propeptides, added in 
trans to the mature enzymes (Taylor et al., 1995; Völkel et al., 1996; Carmona et al., 1996; 
Maubach  et  al.,  1997).  Inhibition  studies  with  cognate,  non-cognate,  and  even  chimeric 
propeptides have shown that the propeptide of cathepsin S is a rather non-specific inhibitor, 
compared  to  the  more  selective  interaction  of  the  propeptides  of  cathepsin  L  and  K, 
respectively (Carmona et al., 1996; Maubach et al., 1997; Guo at al., 2000). Primary structure 
alignment does not reveal any reason for this observation, but tertiary structure superposition 
of the various propeptides may be elucidating. 
1.4.3 Folding competence 
An  interesting  aspect  is  the  propeptide-dependent  folding  of  cathepsin  L-like  subfamily 
members, which has been hypothesized for about one decade (Smith & Gottesman, 1989), but 
has been proven only recently (Yamamoto et al., 1999; Wiederanders, 2000; Schilling et al., 
2001).  As  primary  structure  defines  all  higher  structural  levels  of  a  protein,  such  an 
observation seems to be trivial (Anfinsen & Scheraga, 1975). However, in the case of α-lytic 
protease  (Sauter  et  al.,  1998),  it  was  shown  that  the  propeptide  forms  a  well-structured 
template stabilizing a critical folding transition state of the adjacent enzyme part. This way, 
protease folding is kinetically controlled and thus contributes substantially to the stability of 
the enzyme. Such propeptides may be considered single turnover catalysts and are termed 
foldases or intramolecular chaperones. It is suggested that this function requires a tertiary 
structure  of  the  isolated  propeptide,  which  folds  independently  of  the  other  parts  of  the 
molecule.  Such  an  ordered  structure  was  first  indicated  by  various  spectrospopic  and 
fluorometric investigations on recombinant cathepsin S propeptides (Maubach et al., 1997), 
which fold via pH shift from acidic to neutral pH. Recently, the catalyzed folding of cathepsin 
S as a member of the papain-like cysteine proteases was studied in more detail. An alanine 
scan of more than ten highly conserved amino acids in the proregion revealed their functional 
importance, at the zymogen level in vivo (Kreusch et al., 2000) as well as in vitro, when the 
interaction  of  the  recombinant  propeptide  mutants  with  the  mature  enzyme  in  trans-
experiments was studied (Schilling et al., 2001, Pietschmann et al., 2002).
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                --------α1p-----       ------------α2p------------ 
  +    +                    + 
ProcS    20   KDPTLDHHWHLWKKTYGKQYKEKNEEAVRRLIWEKNLKFVMLHNLEHSMG 69
ProcK    18   PEEILDTHWELWKKTHRKQYNNKVDEISRRLIWEKNLKYISIHNLEASLG 67
ProcL    21   FDHSLEAQWTKWKAMHNRLYG-MNEEGWRRAVWEKNMKMIELHNQEYREG 69
Papain   40   STERLIQLFESWMLKHNKIYKNIDEKIYRFEIFKDNLKYIDETN----KK 85
                                      *   *   *  *   *   * 
         --α3p--- 
       
ProcS    70   MHSYDLGMNHLGDMTSEEVMSLMSSLRVPSQWQRNITYKSNPNRI--- 114
ProcK    68   VHTYELAMNHLGDMTSEEVVQKMTGLKVPLSHSRSNDTLYIPEWEGR- 114
ProcL    70   KHSFTMAMNAFGDMTSEEFRQVMNGFQN--RKPRKGKVFQEPLFYE-- 113
Papain   86   NNSYWLGLNVFADMSNDEFKEKYTGSIAGNYTTTELSYEEVLNDGDVN 133
Figure 1-2 Sequence alignment of propeptides
Sequence alignment of the propeptides of cathepsins S, K, L, and papain. Numbering is given 
for  the  pre-procathepsins  and  pre-propapain.  Residues  of  the  cathepsin  S  propeptide, 
substituted  by  scanning  mutagenesis  and  their  homologues,  are  highlighted  in  red.  The 
residues belonging to the ER(W/F)N(I/V)N-motif are marked with asterisks. The aromatic 
residues belonging to the hydrophobic core are marked with crosses. The sequence regions 
belonging to the helices (procathepsin K) are labeled. 
1.4.4 The  ER(W/F)N(I/V)N-motif  and  the  hydrophobic  core:  functional 
importance
In previous studies, the conserved residues in procathepsin S were subsequently replaced by 
alanins.  In  order  to  elucidate  the  functional  importance  of  the  conserved  motif,  human 
embryonic kidney cells were transfected with the mutants. Only those mutants, in which the 
three tryptophanes of the hydrophobic core (Trp28p, Trp31p and Trp52p) were exchanged, 
showed dramatic  effects.  They were  not  processed to  mature  cathepsin  S,  nor  were  they 
phosphorylated or secreted into the culture medium (Kreusch et al., 2000). Accompanying to 
these  studies,  cathepsin  S  propeptides  with  the  same  mutations  were  expressed  (E.  coli 
inclusion bodies) and refolded. As shown by CD and fluorescence emission spectroscopic 
stopped-flow  and  steady  state  measurements,  the  exchange  of  the  tryptophanes  of  the 
hydrophobic core disturbed the folding process of the propeptide structure.  Only partially 
folded propeptide  structures  were  found,  whereas  the  spectra  of  the  wild-type  propeptide 
point to a proper tertiary structure (Maubach  et al., 1997, Schilling  et aöl., 2001). Another 
consequence of  these  mutations was the  loss  in  folding competence of  the propeptide as 
foldases for cathepsin S, as shown in  in-vitro refolding experiments. Therefore, a dramatic 
decrease  of  the  inhibitory  properties  of  the  cathepsin  S  propeptide  mutants  was  seen  in 
inhibition studies (Schilling et al., 2001, Pietschmann et al., 2002).
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1.5 Aim of the thesis
The aim of this project was to elucidate the structure of human procathepsin S. The strategy 
consisted of the cloning and expression of an inactive proenzyme mutant, which allows the 
crystallization without degradation of the propeptide by activated enzyme molecules. 
The structure of the proenzyme will give insight into the interactions between the N-terminal 
propeptide  and  the  enzyme domains,  and  will  help  to  understand  better  aspects  such  as 
inhibition and folding of cathepsin S by its propeptide. The comparison of the procathepsin S 
structure with other related cathepsin proenzymes should help to explain the oberservations 
concerning the noticeable non-selective inhibition of the cathepsin S propeptide towards other 
related cathepsins as well as the different inhibitory behavior of several cathepsin propeptides 
towards  cathepsin  S.  In  the  recently  determined structures  of  human cathepsin  S  several 
cathepsin S-specific amino acids nearby the active-site have been found. Their functional role 
cannot not be elucidated because an interacting partner of a peptide/substrate is missing. The 
positions  of  the cathepsin S-specific  residues  nearby the substrate-binding sites prompted 
speculations concerning their role in the propeptide enzyme interactions.
Therefore, the crystallization of the expressed cathepsin S propeptide was undertaken in the 
hope  of  a  successful  structure  determination.  The  comparison  of  the  isolated  propeptide 
structure with the respective structural element within the entire procathepsin may yield a 
better insight into the action of the propeptide as foldase and inhibitor. These functions of the 
propeptide  require  a  very  similar  conformation  of  both,  the  isolated  propeptide  and  the 
propeptide part within the entire procathepsin.
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2. MATERIALS 
2.1 Molecular biology
2.1.1 Vectors and plasmids
pTZ 18hCS with full-length insert encoding human procathepsin S (wildtype) in 
pTZ18 vector (Invitrogen); provided by G. Maubach
pcDNA3.1-3/-3+ with full-length insert encoding human procathepsin S (Cys25→Ala 
mutant) in pcDNA3.1 vector (Invitrogen); provided by S. Kreusch
pcDNA3.1-2/3+ with full-length insert encoding human procathepsin S (Cys25→Ser 
mutant) in pcDNA3.1 vector (Invitrogen); provided by S. Kreusch
pASK75-hppCS with insert encoding the cathepsin S propeptide (wildtype) in pASK75 
vector (Biometra); provided by G. Maubach
pBlueBac4.5 Baculovirus Transfer Vector (Invitrogen)
2.1.2 Bacterial strains, media
Strain E.coli TOP 10 F ´ competent cells   Invitrogen
LB-Medium 5g/l yeast extract, 10g/l casitone, 10g/l NaCl, pH 7.4
LB-Ampicilin 
plates
5g/l yeast extract, 10g/l casitone, 10g/l NaCl, 
15g/l bacto-agar, 100µg/ml ampicillin, pH 7.4
All media were autoclaved at 121°C (20 min). Ampicillin was passed through a sterile filter 
(0.22µm) and added after autoclaving.
2.1.3 Kits
Plasmid isolation Qiaspin Miniprep Plasmid Kit                            Qiagen
Purification of PCR products High Pure PCR Purification Kit                     Boehringer
Gel-elution Nucleotrap DNA Extraction Kit     Macherey und Nagel
Sequencing SequiTherm Long-Read Cycle 
sequencing kit
 EpicentreTechnologies
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2.1.4 Enzymes and buffers
DNA-Polymerases Pfu              Stratagene
Taq             Gibco BRL
Ligase T4 DNA Ligase             Gibco BRL
Restriction endonucleases EcoRI             Gibco BRL
BamHI             Gibco BRL
Dpn I             Boehringer 
XbaI             Gibco BRL
HindIII             Gibco BRL
            
Nucleotides dNTP-Mix             Boehringer 
Buffer and additives Buffer React 3             Gibco BRL
Buffer H             Boehringer 
Buffer A             Boehringer 
MgCl2             Gibco BRL
Ligase Buffer             Gibco BRL
2.1.5 Oligonucleotides
The primers used for the generation of PCR products encoding human procathepsin S corres-
pond to positions 158 and 1134 of the cDNA sequence (modified bases are underlined):
• sense 5´- TCACAGGATCCATGAAACGGCTGGTTTG - 3´
• anti-sense 5´- ACGGGGAATTCCTAGATTTCTGGGTAAGAGG - 3´
Primer used for site directed mutagenesis:
Cys25 →Ala : 
• sense 5´- TTGTGGTGCTGCCTGGGCTTTCAGTGCTGTGGG - 3´ 
• antisense 5´- AAAGCCCAGGCAGCACCACAAGAACCTTGATATTTCAC - 3´
Cys25 →Ser:
• sense 5´- TTGTGGTGCTTCCTGGGCTTTCAGTGCTGTGGG - 3´
• antisense 5´- AAAGCCCAGGAAGCACCACAAGAACCTTGATATTTCAC - 3
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2.2 Bacterial expression
2.2.1 Strain and inducer
Bacterial strain E.coli BL21 (DE3) cells for expression   Novagen 
Inducer AHT (anhydrotetracycline) 50µg/l       Merck 
2.2.2 Buffers for cell lysis
Buffer W 100mM Tris/HCl pH 8.0, 1mM EDTA, 0.02% (w/v) NaN3
Buffer X 100mM Tris/HCl pH 8.0, 1mM EDTA, 1% Triton X-100
Buffer S 250mM sucrose, 100mM Tris/HCl  pH 8.0, 1mM EDTA
Buffer V 1mM Tris/HCl pH 8.0, 1mM EDTA
Buffer D 50mM NaCl, pH 4.5, 6M GdnHCl
Buffer D1 50mM NaCl, pH 4.5, 0.5M GdnHCl, 15% acetonitril
2.3 Baculovirus expression
2.3.1 Insect cell culture
Insect cells Sf9 (Spodoptera frugiperda)            Invitrogen 
HighFive (Trichoplusia nigra)            Invitrogen 
2.3.2 Bac-N-Blue Kit (Invitrogen)
The Bac-N-Blue Kit (Invitrogen) was used for the infection of insect cells. The contents are 
listed  below. 
Cell-specific liposomes InsectinPlus (1% v/v)
Transfer vector pBlueBac4.5 (Baculovirus Transfer Vector)
Viral DNA Bac-N-Blue DNA 
2.3.3 Media And supplements
Media EXCELL 400 insect media  JRH Biosciences
Antibiotics Gentamycin (10µg/ml final concentration)          Gibco BRL
Serum fetal calf serum (10% v/v)             Biochrom
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2.3.4 Culture equipment
Culture flasks 25 - 200 cm² flask           Greiner
2.4 SDS-Page and Western blot
2.4.1    Antibodies 
Primary antibody Polyclonal antisera from rabbit against human 
cathepsin S, obtained by immunization with recom-
binant human cathepsin S (Sascha), provided by E. 
Weber (University Halle)
Secundary antibody Anti-IgG Rabbit, coupled with peroxidase             Sigma
2.4.2    Buffers and solutions
SDS-Page Loading buffer: (5x) 2,5ml SDS (20%), 1ml glycerol, 
1,5ml 1M Tris/HCl pH 6.8, 0.55ml β-mercaptoethanol, 
bromphenolblue
Running buffer: Tris/glycine-buffer (5x): 15g/l Tris, 
72g/l glycin, 5g/l SDS
Washing buffer: (5x) 12g/l Tris, 45g/l NaCl, 
2.5ml/l Triton X-100, 7.2ml/l HCl,  pH 7.5 - 7.6
Western blot Blot buffer: (10x) 30.3g/l Tris, 144g/l glycin, pH 8.3
Block solution: 5% milk powder in washing buffer
Staining solution: 6mg nitrobluetetrazoliumchloride, 
20mg NADH, 10µl Phenol, 10µl H2O2 
in 20ml washing buffer
Molecular weight 
standard
Prestained SDS-PAGE Standards Low Range                          Bio-Rad
Benchmark  Prestained Protein Ladder                             Gibco BRL
2.4.3 Protein purification 
Affinity chromatography Concanavalin A Sepharose   Pharmacia 
Washing buffer: 50mM Tris/HCL, 0.5M NaCl,
3mM NaN3, pH 7.5
Binding buffer: 50mM Tris/HCL, 0.5M NaCl, 
3mM NaN3, 1mM CaCl2, 1mM MnCl2, 1mM 
MgCl2, pH 7.5
Elution buffer: 50mM Tris/HCL, 0.5M NaCl, 
3mM NaN3, pH 7.5 
+ 0.25M methyl-α-D-mannopyranoside 
        
         Merck
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Gelfiltration Superdex G75 26/60 Column    Amersham
Washing and Elution buffer: 50mM Tris/HCl, 
0.5M NaCl, 3mM NaN3, pH 7.5
Determination of
protein concentration
Bio-Rad-Protein-Assay
method according to Bradford (Bradford, 1976)
       Bio-Rad 
Protein concentrator Amicon Concentrator       Millipore 
Centricon Plus-20 (5000 NMWL) Biomax-5       Millipore 
2.5 Crystallization materials and cryo tools
Centricon Plus-20 centrifugal filter devices and Ultrafree-MC filter 
units
                    Millipore
Glass sample capillaries                          GLAS 
Highly liquid paraffin oil                          Merck 
High vacuum grease              Dow Corning 
Magnetic base crystal caps     Hampton Research 
mounted cryoloops     Hampton Research 
24-well Linbro plates and VDX plates     Hampton Research 
22mm circular siliconized coverslips     Hampton Research 
sealing wax     Hampton Research 
Crystal Screens 1 and 2     Hampton Research 
crystal storage vials     Hampton Research 
cryo canes     Hampton Research 
magnetic crystal wands     Hampton Research 
curved vial clamps and microtools     Hampton Research 
2.6 Additional equipment
Electrophoresis Mini-Protean II                      Bio-Rad
Protein-Blot Trans-Blot Semi-Dry                      Bio-Rad 
Sequencer Li-Cor 4000L            MWG Biotech 
Ultrasonication Bandelin Sonoplus HD 70   Bandelin Electronics 
Thermocontroler PTC-100       MJ Research, Inc.
Thermocycler Progene                        Techne 
Centrifuges MC 12V                        Sorvall 
Megafuge 1.0R   Heraeus Instruments 
L70                     Beckman 
RC5B                        Sorvall 
Heraeus Labofuge 400R   Heraeus Instruments 
Heraeus Biofuge plus   Heraeus Instruments 
Spectrophotometer UV Vis Spekol                            Zeiss 
UV 1202 Photometer                 Labsystems 
Fluorimeter Fluoroscan II-reader                      Sartorius 
Analytical balance Sartorius BP 210 D                      Sartorius 
Table balance Sartorius portable PT2100                      Sartorius 
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pH meter Sartorius portable PT2100                     Millipore 
Water purification Milli-Qplus 185                     Olympus 
Microscope Olympus SZH10 binocular                            Zeiss 
Zeiss Stemi 1000 binocular
Data collection
                       
X-ray generator Rotating anode Nonius FR591                        Nonius 
Image plate detector Mar 300              Mar Research 
Mar 345              Mar Research
Image plate detector Dip 2030K                        Nonius  
Cryostat Oxford controller 600 series               Oxford Cryo 
Air stream cooler FTS TC-84               FTS systems 
X-ray mirror system MAC-XOS                MacScience
Synchrotron Joint IMB Jena-University of Hamburg-
EMBL synchrotron beamline X13 and 
EMBL beamline X11 at DESY Hamburg
                              
Computing Indy workstation                              SGI 
Onyx graphics workstation                              SGI 
O2 graphics workstation                              SGI 
Indigo2 graphics workstation                              SGI
2.7 List of suppliers in alphabetical order
Amersham
Bandelin Electronics
Beckman
Biochrom
Biometra
Bio-Rad
Boehringer
Dow Corning
Epicentre Technologies
FTS systems
Gibco BRL
GLAS
Greiner
Hampton Research
Heraeus Instruments
JRH Biosciences
Invitrogen
Labsystems
Uppsala, Sweden
Berlin, Germany
München, Germany
Terre Haute, Indiana, USA
Göttingen, Germany
München, Germany
Mannheim, Germany
Midland, USA
Madison, USA
Stone Ridge, USA
Karlsruhe, Germany
Berlin, Germany
Frickenhausen, Germany
Laguna Niguel, USA
Hanau, Germany
Lenexa, USA
Leek, The Netherlands
Egelsbach, Germany
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Macherey und Nagel
MacScience
Mar Research
Merck
Millipore
MJ Reseach, Inc.
MWG Biotech
Nonius
Novagen
Oxford Cryo
Olympus
Pharmacia
Qiagen
Sartorius
Schott
SGI
Shimadzu
Sigma
Sorvall
Stratagene
Techne
Zeiss
Düren, Germany
Yokohama, Japan
Hamburg, Germany
Darmstadt, Germany
Eschborn, Germany
San Francisco, USA
München, Germany
Delft, The Netherlands
Lund, Sweden
Oxford, United Kingdom
Hamburg, Germany
Freiburg, Germany
Hilden, Germany
Göttingen, Germany
Jena, Germany
Mountain View, USA
Duisburg, Germany
Taufkirchen, Germany
Bad Homburg, Germany
Amsterdam, The Netherlands
Cambridge, United Kingdom
Jena, Germany
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3.  Methods
3.1  Cloning 
3.1.1  Cloning of the human procathepsin S gene 
3.1.1.1  Plasmid preparation
Plasmid DNA was purified and desalted using Qiaspin Miniprep Plasmid Kit (Quiagen) ac-
cording to the manufacturer´s instruction.
3.1.1.2  Amplification of target DNA using polymerase chain reaction (PCR)
The plasmids pTZ 18hCS (wildtype), pcDNA3.1-3/-3+ (Cys25→Ala), and   pcDNA3.1-2/3+ 
(Cys25→Ser), which contain the cDNA encoding the preproenzyme of human cathepsin S 
were used as templates for the PCR. The complete sequence was amplified using the forward 
primer  5´-TCACAGGATCCATGAAACGGCTGGTTTG-3´  and  the  reverse  primer  5´- 
ACGGGGAATTCCTAGATTTCTGGGTAAGAGG-3´ for PCR. The primers were deduced 
from positions 158 and 1134 of the cDNA sequence. The sense primer contains a BamHI site 
(italics) and a codon for one additional N-terminal methionine (underlined), the anti-sense 
primer an EcoRI site (italics). The reaction mixture was assembled in a single tube, and then 
placed in the thermal cycler.
Amplification of human the gene encoding wildtype procathepsin S (pTZ 18hCS):
PCR-conditions
Reaction volume is 50µl: 10 - 20 ng DNA template 
20 pmol primer
1.5 µl 50mM MgCl2
2.0 µl 10mM dNTP Mix (Boehringer)
5.0 µl 10x PCR buffer for Taq polymerase (Gibco BRL)
2 U Taq polymerase (Gibco BRL)
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Thermocycler programme  
                                             Initial Denaturation Step: 95°C 3 min.
Hotstart (adding of polymerase): 80°C
27 cycles Denaturation Step: 94°C 30 sec.
Primer Annealing Step: 54°C 30 sec.
Extension Step: 72°C 60 sec.
Final Extension Step: 72°C 10 min.
Amplification of the genes encoding mutated procathepsin S (pcDNA3.1-3/-3+ and pcDNA3.1-
2/3+):
PCR conditions
Reaction volume of 50µl: 80-90ng DNA template 
20pmol primer
            1.0µl 10mM dNTP-Mix (Boehringer)
5.0µl 10x PCR-buffer for Pfu polymerase (Stratagene)
1.25U Pfu polymerase (Stratagene)
 
Thermocycler program  
                                             Initial Denaturation Step: 95°C 3 min.
Hotstart (adding of polymerase): 80°C
27 cycles Denaturation Step: 94°C 30 sec.
Primer Annealing Step: 57°C 30 sec.
Extension Step: 72°C 60 sec.
Final Extension Step: 72°C 10 min.
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3.1.1.3  Site-directed mutagenesis
The plasmids pcDNA3.1-3/-3+  and pcDNA3.1-2/3+ containing the inserts encoding Cys25→
Ala/Ser mutants of human procathepsin S were constructed by Stefan Kreusch in order to 
eliminate autocatalytic processing of the protein. Substitution of the active-site cysteine with 
alanine produced a catalytically inactive protein that was unable to independently process 
itself  to the mature enzyme. The substitution was introduced by PCR-based site- directed 
mutagenesis according to the ExSiteTM protocol (Stratagene). 
PCR conditions
Reaction volume is 25µl: 300ng DNA template 
20pmol primer
3.0µl 50mM MgCl2
            3.0µl 10mM dNTP-Mix (Boehringer)
2.5µl 10x PCR-buffer for Pfu polymerase (Stratagene)
1.25U Pfu polymerase (Stratagene)
 
Thermocycler program  
                                             Initial Denaturation Step: 95°C 3 min.
Hotstart (adding of polymerase): 80°C
4 cycles Denaturation Step: 94°C 30 sec.
Primer Annealing Step: 58°C-0.2°C/cycle 30 sec.
Extension Step: 72°C 8 min.
12 cycles Denaturation Step: 94°C 20 sec.
Primer Annealing Step: 58°C-0.2°C/cycle 30 sec
Extension Step: 72°C 6 min.
Final Extension Step: 72°C 10 min.
3.1.1.4  Selection of PCR products for ligation and transformation
The PCR-amplified DNA fragments were separated using agarose gel electrophoresis (1% 
agarose, 1x TAE-buffer, 100 V at room temperature) and cut out while exposing to UV light. 
The  DNA was  eluted  using  the  NucleotrapDNA Extraction  Kit  (Macherey  und  Nagel) 
according  to  manufacturer´s  instruction.  After  extraction,  the  DNA was used  for  ligation 
setups.  Another  way  consists  of  the  selective  digestion  with  the  restriction  endonuclease 
20
-----------------------------------------------------------------------------------------------------------------Methods
DpnI, which cuts the DNA sequence G- mA-T-C to produce flush ends. This enzyme requires 
the methylation of adenines in both strands of the DNA in order for cleavage to occur. This 
way, digestion of the original template can be achieved, and only mutated PCR products will 
be isolated, since the non-methylated PCR-products cannot be cleaved by DpnI.
Procedure: Reaction volume of 100µl: 50µlPCR reaction assay
5µl10x restriction buffer A (Boehringer)
1µl  DpnI (2U) (Boehringer)
44µl  Aqua bidest.
Incubation overnight at 37°C.
3.1.1.5  Desalting of plasmid DNA
To avoid unfavourable ligation conditions, the PCR products were purified from contaminants 
like dNTPs, primers, and short restriction fragments using the High Pure PCR Purification Kit 
(Boehringer).
.
3.1.1.6  Ligation of PCR products with the baculovirus transfer vector
The PCR products were ligated into the multiple cloning site of the pBlueBac4.5 baculovirus 
transfer vector (Invitrogen).
Ligation over night at 14°C wild-type Cys25→Ala Cys25→Ser
PCR-product  3µl / 15ng 6µl / 15ng 15µl / 15ng
10x Ligation buffer (Gibco) 4µl 4µl 4µl
 PBlueBac4.5-vector  
(cleaved at BamHI / EcoRI sites) 15µl / 60ng 15µl / 60ng 15µl / 60ng
T4-DNA Ligase (Gibco) 1µl / 4U 1µl / 4U 1µl / 4U
Aqua bidest. 17µl 14µl 5µl
Reaction volume 50µl 50µl 50µl
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3.1.1.7  Transformation of competent E. coli cells
Aliquots of the ligation reaction mixtures were transformed into E. coli TOP 10 F´ competent 
cells  (Invitrogen)  according  to  the  manufacturer’s  instruction.  100  and  150  µl  of  the 
transformed cultures were plated on LB plates containing 50µg/l ampicillin. and incubated at 
37°C overnight.
 
3.1.2 Cloning of the cathepsin S propeptide
The vector pASK75-hppCS contains the cDNA encoding the propeptide of human cathepsin 
S  (amino  acids  16  to  114),  which  had  been  cloned  into  the  pASK75 expression  vector 
(Biometra) by G. Maubach (Maubach  et al. 1997). Downstream of the tet-promoter region, 
the  plasmid  contains  the  signal  sequence  of  ompA,  which  enables  the  transport  of 
recombinant proteins into the periplasma. A C-terminal fusion tag, the Strep-tag, encodes a 
ten amino acid sequence that binds streptavidin. The affinity of the tag for streptavidin allows 
a one-step purification of recombinant proteins. The expression of the recombinant cathepsin 
S propeptide into the bacterial periplasm as well as the purification of tagged soluble protein 
using Streptavidin-sepharose failed. In order to express and purifiy the protein from inclusion 
bodies, the ompA sequence and the Strep-tag were deleted using site-directed mutagenesis. 
The plasmids were transformed into E.coli BL21 (DE3) cells for expression. 100 and 150µl of 
the  transformed cultures  were   plated  on  LB plates  containing  50  µg/ml  ampicillin.  and 
incubated at 37°C overnight. 
3.1.3  Sequencing
All inserts were sequenced to check the correct amplification and ligation using the `cycle-
sequencing´ method, a combination of the Sanger dideoxy method and PCR. Following the 
standard  protocol,  the  SequiTherm Long-Read Cycle  sequencing  kit  (Epicentre 
Technologies) was used. For the sequencing a LI-COR 4000L Sequencer was used.
Thermocycler program  
                                              Initial Denaturation Step: 95°C     2 min.
31 cycles Denaturation Step: 94°C    15 sec.
Primer Annealing Step: 50-64°C 15 sec.
Extension Step: 72°C    30 sec.
Cooling Down Step 4.0°C    10 min.
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3.2 Expression
3.2.1 Expression of recombinant human procathepsin S in insect cells
3.2.1.1 Cell culture
Spodoptera frugiperda Sf9 and Trichoplusia nigra HighFive cells (Invitrogen) were grown 
at  27°C  in  EXCELL  400  insect  medium  (JRH  Biosciences)  supplemented  with  heat-
inactivated  10% fetal  calf  serum (Biochrom)  and  10  µg/ml  gentamycin  (Gibco  BRL)  as 
antibiotic. The cells were grown as suspension cultures in 175 cm² flasks (Greiner). At a cell 
density of 2.5 x 106 cells/ml the cells were diluted back to 1.0 x 106 cells and distributed into 
new flasks. The number of cells was counted microscopically using a `Neubauer Zählkammer
´. 
3.2.1.2 Transfection  of  insect  cells  and  homologous  recombination  between  the 
transfer vector and linearized Bac-N-Blue AcMNPV DNA
For the transfection of the recombinant DNA into Sf9 cells, the Bac-N-Blue Kit (Invitrogen) 
was  used  according  to  the  manufacturer´s  instructions.  Viral  Bac-N-  Blue DNA, 
recombinant  transfer  DNA  (pBlueBac4.5-vector  containing  the  insert  encoding  human 
procathepsin S wild-type and mutants), and cell specific liposomes InsectinPlus were mixed 
together in EXCELL 400 insect cell media (without FCS and supplements) and incubated 
with freshly seeded insect cells.
Transfection mixture:
In a 1.5 ml microcentrifuge tube containing 10µl (0.5µg) Bac-N- Blue DNA, the following 
reagents were added: Recombinant transfer plasmid (1µg/µl)          4µl (4µg)
EXCELL 400 media (without FCS)            1ml
InsectinPlus Liposomes           20µl
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After vortexing, the transfection mixture was incubated at room temperature for 15 minutes 
and then added dropwise onto the monolayer of  Sf9 cells, which had been grown adherently 
grown in a 60mm dish. The dishes were incubated at room temperature for 4 hours on a rock-
ing platform. One dish without added transfection mixture was incubated as cell-only control. 
After an incubation period of 4 hours, 1ml complete EXCELL 400 medium (including 10% 
FCS and 10 µg/ml gentamycin) was added to each dish. The dishes were sealed in  plastic 
bags and incubated at 27°C for 72 hours. After approximately 72 hours, budded virus was re-
leased into the medium. This transfection supernatant was harvested and assayed for recombi-
nant plaques (the transfection viral stock). 2 ml of the medium from each dish of transfected 
cells were transferred into a sterile 15ml polypropylene tube and stored at  + 4°C. To control 
the success of transfection, 3 ml of fresh complete medium were added to the transfected 
cells. The cells were incubated for a further 7 days and visually checked for the following 
events, which indicate a successful transfection:
Early phase: Increased cell diameter by 25 - 50%.
       Increased size of cell nuclei, which may appear to fill the cells.
Late phase:       Cells appear to stop growing when compared to a cell-only control.
Granular appearance. Signs of viral budding; vesicular appearance 
 to  cells.  Viral  occlusion  bodies  in  a  few  cells,  which  appear  as 
refractive crystals in the nucleus of the insect cell.
Very late phase: Cell lysis of a few dead cells filled with occluded virus
   
3.2.1.3   Isolation of recombinant virus (Plaque assay)
To avoid the dilution of the recombinant virus by wild-type virus with time, which infects and 
replicates more efficiently than recombinant virus, the recombinant virus titer was purified 
from uncut viral DNA background (occlusion body, occ+) and illegitimate (non-homologous) 
recombinants not containing the human procathepsin S gene (wild-type and mutants).  The 
plaque  assay  was  performed  according  to  the  manufacturer´s  (Invitrogen)  instructions  as 
briefly described below:
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• Sf9 insect cells were seeded on 100mm plates at 5 x 106 cells/plate and grown till 50% 
confluence in order to allow cells to double before growth ceases.
• The cells were infected with the 10-2, 10-3, and 10-4 dilutions of transfection viral stock 
(coding for human procathepsin S wild-type, Cys25→Ala, and Cys25→Ser mutants) for 1 
hour at 27°C.
• The medium was removed. The cells were overlayed with a mixture of 2.5% low melting 
Baculovirus  Agarose  (Invitrogen),  complete  EXCESS  400  medium  (+  10%  FCS  and 
10µg/ml gentamycin), and 50 µg/ml X-Gal (for blue-white screening of positive plaques). 
After polymerization of the agarose/medium mixture the plates were incubated at 37°C 
until plaques were formed.
After infection of a few cells, these cells lysed and released virions, which infected nearby 
cells, that lysed too. This procedure led to the release of more and more virions, which subse-
quently infected other neighbouring cells. The recombinant virus produced ß-galactosidase, 
which resulted in blue plaques of infected cells because of the hydrolysis of the chromogenic 
substrate. After 5-6 days, blue plaques were detected and isolated for further analysis.
3.2.1.4   PCR analysis of recombinant viral DNA
The PCR allows a quick, safe and non-radioactive method to determine the presence of the in-
sert encoding procathepsin S in the recombinant virus and to confirm the isolation of pure, re-
combinant  plaque.  The procedure was performed according to the manufacturer´s  instruc-
tions:
• A 12-well microtiter plate was filled with 2ml of complete EXCELL 400 insect medium 
(Invitrogen) per well. 5 x 105 log-phase Sf9 cells (1 ml) were seeded per well.
• Using a Pasteur pipette, recombinant plaques (blue coloured) were picked as agarose plugs. 
One agarose plug was transferred into each well. One well was used for the occ+ plaque 
assay (wild-type Bac-N- Blue DNA) and another as a cells-only control.
• The microtiter plate was sealed with parafilm and incubated at 27°C for 3 days.
• After 3 days, the wells were visually screened for the presence of occlusion bodies. (occ+).
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• 750µl of the infected cell suspension of occ- wells (without occlusion bodies in the cells) 
and the one occ+ cell  suspension (wild-type Bac-N- Blue DNA) were used for DNA 
isolation.
In the next step the recombinant and wild-type virus DNA was isolated as described below:
• Removal  of  the  cell  debris  by  centrifugation  in  a  microcentrifuge  at  5000  rpm for  3 
minutes.
• After transfer of the supernatant into a fresh tube, 750µl of cold (4°C) 20% polyethylene 
glycol (PEG) in 1 M NaCl were added. The solution was mixed and incubated at room 
temperature for 30 minutes.
• After incubation and centrifugation of the mixture at maximum speed for 10 minutes at 
room temperature, the supernatant was carefully removed from the pellet.
• The pellet  was resuspended in 100 µl  sterile  water,  10 µl  proteinase K (5mg/ml)  was 
added, and the mixture was incubated at 50°C in a heat block for 1 hour. 
• After extraction with an equal volume (110 µl) of phenol-chloroform (1:1), the mixture 
was  centrifuged  at  maximum  speed  in  a  microcentrifuge  for  5  minutes  at  room 
temperature, resulting in a phase separation. The upper aqueous phase was transfered to a 
fresh, sterile tube.
• The DNA was precipitated by adding 1/10 volume (11 µl) of 3 M sodium acetate and 2 
volumes (220 µl) of 100% ethanol. The mixture was incubated for 20 minutes at -80°C.
• After  centrifugation  of  the  mixture  at  maximum  speed  for  15  minutes  at  4°C  the 
supernatant  was  removed  from  the  pellet.  The  pellet  was  washed  with  70%  ethanol 
followed by centrifugation. All traces of ethanol were removed from the pellet.
• The pellet was resuspended in 10 µl sterile water and used for PCR setups.
Commercially  available  primers  (Invitrogen)  were  used  for  PCR  with  virus  DNA.  The 
forward and reverse primer had been designed to flank the polyhedrin region. These primers 
are compatible with all polyhedrin promoter based baculovirus transfer vectors. The forward 
primer binds from -44 (nt 4049) to -21 (nt 4072) downstream of the polyhedrin gene, using 
the nomenclature of O´Reilly  et al. (1992). The reverse primer binds at +794 (nt 4886) to 
+774 (nt 4866), upstream of the polyhedrin gene.
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• Forward primer (-44): 5´- TTTACTGTTTTCGTAACAGTTTTG - 3´
• Reverse primer (+794): 5´- CAACAACGCACAGAATCTAGC - 3´
Since the size of the foreign gene insert is known, the size of the expected PCR product can 
be determined and wild-type contamination detected:
• Size of expected PCR fragments (wild-type Bac-N- Blue DNA):
     
    839 bp (control)
• Size of expected PCR fragments (pBlueBac4.5 Transfer Vector):     435 bp (control)
• Size of human procathepsin S (wt and mutants) insert:   1018 bp
• Size of expected PCR fragment cloned into pBlueBac4.5 Transfer 
Vector:
 
   435 bp
+ 1018bp
= 1453 bp
PCR conditions
Reaction volume of 50µl: 10ng  DNA template
20pmol  Primer
   1.5µl  50mM MgCl2
2.0µl  10mM dNTP Mix (Boehringer)
5.0µl  10x PCR buffer for Taq polymerase (Stratagene)
1.5U  Pfu polymerase (Stratagene)
Thermocycler programme  
                                             Initial Denaturation Step: 95°C 3 min.
Hotstart (adding of polymerase): 80°C
4 cycles Denaturation Step: 94°C 1 min.
Primer Annealing Step: 55°C 1 min.
Extension Step: 72°C 3 min.
30 cycles Denaturation Step: 94°C 1 min.
Primer Annealing Step: 58°C 1 min.
Extension Step: 72°C 3 min.
Final Extension Step: 72°C 7 min.
After the PCR prodedure the samples were analyzed on a 1% agarose gel.
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3.2.1.5   Preparation of  high-titer viral stocks
Corresponding  to  the  positive  plaque  clone,  the  pure  recombinant  virus  stock  (P-1 viral 
stock)  was identified.  In the last  step,  a high-titer  viral  stock was generated as described 
below:
• 2 cm² flasks were seeded with 2 x 106 log-phase Sf9 cells (98% viable, doubling every 
18-24 hours) in 5 ml complete EXCELL 400 medium. 20µl of the P-1 viral stock (human 
procathepsin S wild-type and Cys25→Ala/Ser mutants)  were added to each flask and 
incubated at 27°C until the cells were 100% lysed. The medium containing the lysed cells 
(10 ml) is the P-2 viral stock, a small-scale, high-titer stock. 1 ml of this stock was stored 
at -80°C for long-term storage. 
• 5ml of the P-2 viral stock were added to 500ml suspension of log-phase Sf9 cells seeded 
at a density of 2.5 x 106 cells/ml. The cells were incubated for 12 days on a rocking 
platform at 27°C. After cell lysis, the suspension was centrifugated at 1000 rpm for 20 
minutes. The supernatant was transferred to a sterile bottle and stored at 4°C. This  P-3 
viral stock, a large-scale, high-titer stock was used for the infection of HighFiveTM insect 
cells and the expression of the recombinant protein.
3.2.1.6   Infection of HighFiveTM insect cells and expression of recombinant protein 
HighFiveTM insect cells (Invitrogen) were used for the expression of recombinant human 
procathepsin S and its mutants. These oocytes from  Trichoplusia nigra can be cultivated 
under serum-free conditions. The recombinant proteins are released into the culture medium, 
thereby  facilitating  the  subsequent  purification  of  the  expressed  protein.  At  first,  the 
expression rate was tested:
• Log-phase  HighFiveTM insect  cells  (5  x  106 cells/ml  in  20ml  EXCELL 400 medium, 
serum-free) were seeded in 200 cm² flasks.
• 2 ml of the P-3 viral stock (human procathepsin S wild-type, Cys25→Ala, and Cys25→
Ser mutants) were added. The suspension was incubated 1 hour on a rocking platform at 
27°C.
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• After 1 hour, the suspensions were centrifuged (10 minutes at 27°C, 1000 rpm) and the 
supernatants containing the virus stocks from the pellets removed.
• The pellets were resuspended in 20 ml fresh EXCELL 400 medium.
• Incubation for 60 hours on a rocking platform at 27°C.
• After incubation the suspensions were centrifuged (15 minutes at 4°C, 5000 rpm) and the 
supernatants containing the recombinant proteins were aliquoted and stored at -20°C.
3.2.1.7   Large-scale expression of the human procathepsin S Cys25→Ala mutant
The large-scale expression was performed by Dr. G. Schmid (Fa. HoffmannLaRoche, Basel, 
Switzerland) in an Airlifter system. 1.3 x 106 HighFiveTM cells/ml were seeded in 24 liters 
serum-free medium. After inoculation with 480 ml virus titer, the suspension was incubated 
for 60 hours at  27°C. The cells were spun down in a big kontifuge at 15,000 rpm. The 
supernatant was ten-fold concentrated (ca. 2.5 liter) and stored in aliquots at -20°C. 
3.2.2    Expression of the cathepsin S propeptide in E.coli
As previously described by Maubach et al. (1997), the following steps were carried out:
• 1 ml of a glycerol stock of  E. coli BL21 (DE3) cells (Novagen) transformed with the 
pASK75-hppCS were added to 100 ml LB medium and incubated on a rocking platform 
at 30°C. Cell proliferation was monitored until the culture had reached an absorbance of 
0.5 at 550 nm. 
• The expression was induced by addition of 50µg anhydrotetracycline/l culture medium. 
After 3 hours of further incubation, the cells were harvested by centrifugation at 6000 
rpm for 12 minutes. 
• The cells containing the recombinant propeptide in inclusion bodies were resuspended in 
Buffer X and disrupted by sonification (3 cycles, 1 min.., 70 W). 
• After centrifugation at 14,000 rpm for 12 minutes, the pellet was washed in Buffer X and 
then resuspended in Buffer S for subsequent purification using sucrose density-gradient 
centrifugation.
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3.3 Purification
3.3.1 Purification of the human procathepsin S (Cys25→Ala) mutant 
An XK 16/20 column (Amersham Pharmacia Biotech)  was packed with 50 ml concanavalin 
A sepharose (Amersham Pharmacia Biotech) resin and  equilibrated with 0.1 M Tris  ⋅ HCl 
buffer, pH 7.4,  containing 0.5 M NaCl, 1 mM CaCl2, 1 mM MgCl2 and 1 mM MnCl2. The 
supernatant was loaded onto the column at a flow rate of  2 ml/min. After washing the column 
with 3 column volumes of  0.1  M Tris  ⋅ HCL buffer, pH 7.4, containing 0.5 M NaCl, the 
human procathepsin S mutant was eluted with the washing buffer containing 0.25 M methyl-
α-D-mannopyranoside.  The  final  purification  of  the  recombinant  human  procathepsin  S 
mutant to electrophoretic homogeneity was achieved by gel filtration on a HiLoad Superdex-
75 16/60 column (Amersham Pharmacia Biotech). The protein solution was loaded onto the 
column at a flow rate of  1 ml/min.  The collected fractions, containing procathepsin S, were 
pooled and concentrated to  7.0 mg/ml by ultrafiltration (Amicon Centricon Plus-20, 5000 
NMWL Millipore-Biomax 5).
3.3.2 Purification of the human cathepsin S propeptide 
According to the previously described procedure (Maubach et al., 1997), the inclusion bodies 
were purified by sucrose density gradient centrifugation (30 ml, 40-70% (w/w) sucrose in 
1mM Tris/HCl (pH 8.0), 1 mM EDTA) at 28,000 rpm for 2 hours at 4°C. Fractions containing 
the propeptide were pooled, washed with Buffer V and then solubilized with 6 M GdnHCL in 
50mM sodium-acetate buffer (pH 4.5) over night. In a final step, the protein was purified by 
gel filtration chromatography. 1-2 ml of concentrated protein solution were loaded onto a 
HiLoad Superdex-75 16/60 column (Amersham Pharmacia Biotech). Buffer D1 was used as 
the running buffer.  The gel  filtration chromatography was carried out at  a flow-rate  of 1 
ml/min.  The  collected  fractions  containing  the  cathepsin  S  propeptide  were  pooled  and 
concentrated  to   7.5  mg/ml  by  ultrafiltration  (Amicon  Centricon  Plus-20,  5000  NMWL 
Millipore-Biomax 5). The buffer was replaced by 50mM sodium-acetate (pH 4.5) containing 
15 % acetonitrile.
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3.3.3    Protein analysis
Both protein samples were analysed using SDS-PAGE gel electrophoresis, Western-Blot, and 
Coomassie Blue staining. 
• SDS-polyacrylamide  gel  electrophoreses  was  carried  out  at  denaturing  conditions 
(Laemmli, 1970) using 12.5% or 15% gels for separation.
 
• For immunoblotting, the gel was transferred onto nitrocellulose (0.45 µm Amersham or 
Sartorius)  using  a  semi-dry  electrotransfer  unit  at  15  Volt  for  20  minutes.  For 
immunostaining  the  membrane  was  saturated  for  1  hour  with  block  solution  at  room 
temperature.  The  diluted  primary  antibody  (Sascha)  was  added  and  the  incubation 
continued  overnight.  The  membrane  was  then  washed  three  times  (15  minutes)  and 
incubated with the secondary antibody (Anti-IgG Rabbit, coupled with peroxidase) for 1 
hour.  After additional washing (5 x 5 minutes),  the membrane was incubated with the 
staining solution. The reaction was stopped by washing with water. 
• For  Coomassie  staining,  the  gel  was  immersed  in  Coomassie  Blue  solution  (450  ml 
methanol, 90ml acetic acid, 2.5ml Coomassie Blue, 450 ml Aqua bidest.) for 1 hour and 
destained overnight in destaining solution (520 ml H2O, 400 ml methanol, 80 ml acetic 
acid).
 
• The concentration of procathepsin S was measured at 595nm using the Bradford / Bio-Rad 
- Protein Assay dye solution against a BSA standard (Bradford, 1976). The concentration 
of  the  propeptide  was  calculated  from  A280 measurements  in  the  presence  of  15% 
acetonitrile, using a molecular coefficient of 27,880 cm² M-1 as calculated from the amino 
acid composition.
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3.4     Crystallization
Crystallization experiments were carried out using the hanging drop vapor diffusion method 
(McPherson  et al.,  1982, 1999), initially with Hampton Research crystal screens I and II. 
Further  screens  were  continued  with  solutions  prepared  in  the  own  lab.  Also,  the  gel 
acupuncture approach / counter diffusion technique (Garcia-Ruiz  et al., 1994) was used in 
order to grow cathepsin S propeptide crystals (see Results). 
3.5 Collection of diffraction Data
The  crystals  were  flash-cooled  in  a  100  K  nitrogen  stream  generated  by  an  Oxford 
Cryostream cooling system (Oxford Cryosystems, Oxford, United Kingdom). The diffraction 
data were initially collected using an FR591 rotating copper anode X-ray generator (Nonius, 
Delft, The Netherlands) equipped with a 30-cm Mar Research image plate (X-ray Research, 
Hamburg, Germany). 
3.5.1 Data collection of the cathepsin S propeptide crystals
Full datasets were collected using the Joint IMB Jena-University of Hamburg-EMBL syn-
chrotron beamline X13 at Deutsches Elektronen-Synchrotron, Hamburg, at a wavelength of 
0.803 Å and the beamline X11 (EMBL/DESY) at a wavelength of 0.9101 Å to maximum 3.5 
Å resolution. 
3.5.2 Data collection of procathepsin S crystals
Diffraction  data  were  initially  collected  using  an  FR591  rotating  copper  anode  X-ray 
generator (Nonius, Delft, The Netherlands) equipped with a 30-cm Mar Research image plate 
(X-ray Research, Hamburg, Germany). No further cryoprotectant was needed in addition to 
the polyethylene glycol in the mother liquor. Data extending to 3.0 Å were collected over a 
crystal rotation range of 105°, as recommended by the program STRATEGY (Ravelli et al., 
1997). Subsequently, a full dataset to 2.1 Å resolution was collected using the Joint IMB 
Jena-University  of  Hamburg-EMBL  synchrotron  beamline  X13  at  Deutsches  Elektronen-
Synchrotron,  Hamburg,  at  a  wavelength of 0.803 Å. Diffraction intensities were recorded 
using a Mar Research CCD detector (X-ray Research, Hamburg, Germany). 
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3.6 Data processing
The  diffraction  data  were  indexed,  integrated,  and  scaled  using  the  HKL  package 
(Otwinowski  et  al.,  1997).  TRUNCATE  (CCP4,  1994)  was  used  to  derive  structure 
amplitudes from the measured intensities.  
3.7 Structure solution and refinement
3.7.1 Procathepsin S Cys25→Ala mutant
The alignment of amino-acid sequences of different members of the papain-like proteinases, 
especially the L-type cathepsins yielded the highest homology between procathepsin S and 
procathepsin K (~55 %), which had been crystallized in two crystal forms (Sivaraman et al., 
1999, LaLonde et al., 1999). Based on the assumption of a high structural similarity between 
procathepsin S and K, molecular replacement was carried out using the program AMoRe 
(Navaza, 1994), with procathepsin K (LaLonde  et al., 1999) as a search model (PDB entry 
code 1BY8). The rotation function was calculated with reflections between 10 and 4 Å. The 
model was initially refined using CNS (Brünger  et al., 1998). After rigid body refinement, 
simulated annealing,  and energy minimization in  torsion angle space,  the refinement  was 
continued against the synchrotron data that had become available in the meantime. 5% of the 
unique reflections were set aside for the calculations of Rfree (Brünger, 1992). Several cycles 
of  refinement  with  CNS  (Brünger  et  al.,  1998),  which  at  this  stage  consisted  only  of 
minimization  and  B-factor  optimization,  followed by  refitting  on  a  graphical  workstation 
using the program O (Jones et al., 1991). 
3.7.2 Cathepsin S propeptide
Attempts, carried out with molecular replacement are described under Results.
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3.8 Chemical geometry and interactions
The chemical geometry of the structure was checked by Ramachandran plots (Ramachandran 
& Sasisekharan, 1968), calculated with the program PROCHECK (Laskowski et al., 1993). In 
addition, the secondary structure was checked by using the program DSSP (Kabsch & Sander, 
1983). Hydrogen bonds, salt bridges and van der Waals contacts were identified and their 
lengths determined with the program CONTACTS (CCP4, 1994) and further inspected using 
the program O (Jones et al., 1991). CH-pi-interactions were identified with programs written 
by M. Brandl (Brandl et al., 2001) and D. Pal. The selection criteria used to identify a CH-pi-
interaction are shown in Figure 3-1 and described in detail by Brandl et al. (2001). 
Figure 3-1 
Definition of  CH-pi-interactions.
The  pi-system shown as aromatic  ring of a 
phenylalanine. A methionine points towards 
the aromatic ring. The atoms are coloured: C 
(grey), S (yellow) and H (black). 
The center-of- mass is indicated by the point 
X.  The  geometrical  parameters  used  for 
identifying CH-pi-interactions:
The distance between the carbon atoms and 
the center of the  pi-system (dC-X). The maxi-
mum value was set to Ρ 4.5 Å.
The angle at the hydrogen (ρC-H-X) with  ρ Σ 
120°.
The picture was prepared with the program 
SwissPdbViewer (Guex & Peitsch, 1997)
3.9 Electrostatic potential
The electrostatic potential distribution on the surface of the mature cathepsin S molecule as 
well  as  for  the  propeptide  was  calculated  using  the  program Swiss-PdbViewer  (Guex  & 
Peitsch, 1997).  The isoelectric point (pI) for each molecule including the proenzyme was 
calculated with COMPUTE pI/MW (Wilkins et al., 1998).
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4.  Results
4.1  From the gene to the purified recombinant protein
4.1.1  Expression of human procathepsin S and its Cys25→Ala/Ser mutants 
4.1.1.1  Some details on the baculovirus expression system
A very thoroughly investigated eukaryotic expression system is the baculoviruses (O´Reilly et 
al.,  1992, Summers  & Smith,  1988,  Webb & Summers,  1990).  These viruses only infect 
arthropods and even if they are highly virulent for some insects, they are neither virulent for 
vertebrates nor for plants. One of the most studied baculoviruses is the Autographa california 
Nuclear Polyhedrosis Virus (AcNPV) that has been isolated from insect larvae. Like other 
baculoviruses, it has a biphasic life cycle that comprises two different forms of virus: 
1. extracellular  virus  that  buds  from the  cells  is  responsible  for  cell-to-cell  infection  in 
cultured cells or in the insect host. 
2. virus  particles  embedded  in  occlusions  formed  by  a  virus  encoded  protein  (named 
polyhedrin) assure the horizontal transmission of the infection. The occlusions appear 24 
hours after infection and are released into the environment after the death of the infected 
insect larvae. They protect the virus until they are taken up by other insect larvae and 
dissolved by the alkaline intestinal secretions, thus releasing the virus that subsequently 
enters another infectious cycle. 
In cell cultures, the gene coding for polyhedrin is not essential for the infectious cycle and as 
polyhedrin is produced to a very high amount in the infected cells (up to 1mg per 1 to 2 x 106 
cells),  this  gene has  been chosen to  be replaced by a  foreign gene for  the expression of 
recombinant proteins (Smith  et al.,  1983). The foreign gene is first cloned into a plasmid 
transfer vector.  By recombination with the wild-type virus DNA recombinant  baculovirus 
DNA is obtained, that can be used for its high level of protein expression (Smith et al., 1985, 
Matsuura  et  al.,  1987).  In  addition,  expressed  proteins  undergo  eukaryotic-specific 
posttranslational  modifications  such  as  glycosylation  and  polymerization  (Luckow  & 
Summers, 1988). Different proteinases have been successfully expressed in the baculovirus 
system.  Baculoviruses  have  also  been  used  successfully  for  the  expression  of  several 
cathepsins (Steed et al., 1998, Bossard et al., 1996, Brömme & McGrath, 1996, Brömme et 
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al., 1996, Maubach et al, 1997, Mason et al, 2001). The release of the recombinant protein 
into  the  culture  medium  facilitates  the  subsequent  purification.  This  aspect  makes  the 
expression system attractive for a large-scale expression of the protein of interest. 
4.1.1.2 Cloning strategy, preparation and analysis of recombinant virus
Three full length procathapsin S encoding fragments (including the Cys25→Ala and Cys25→
Ser mutants) were cloned into the pBlueBac4.5 baculovirus vector (Invitrogen). This vector 
contains the early-to-late (ETL) promoter and the polyhedrin promoter from AcMNPV (see 
Figure 4-1).
Figure 4-1: 
Cloning strategy for the fragment encoding human procathepsin S Cys25→Ala mutant.
pBlueBac4.5
+
hprocs-Cys25Ala
5.9 kb
pBlueBac4.5
4.9 kb
BamHI
- 3´
5´-
EcoRIAla25
The ETL promoter directs the synthesis of β-galactosidase (Crawford & Miller, 1988) while 
the  polyhedrin  promoter  controls  the  synthesis  of  foreign  gene  products.  The  vector 
recombines  with  modified  wildtype  AcMNPV-DNA  (Bac-N-BlueTM DNA,  Invitrogen)  to 
yield recombinants, which produce foreign gene products and form blue plaques when 5-
bromo-4-chloro-3-indolyl-β-D-galactosidase (X-gal) or a derivative is present in the agarose 
overlay of the plaque assay. Figure 4-1 shows the cloning strategy for the procathepsin S gene 
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into the transfer vector and Figure 4-2 the recombination strategy with the modified wildtype 
AcMNPV-DNA. The last step before proceeding to the virus stock preparation consists of the 
selection of recombinant virus using the plaque assay in order to isolate pure clones. The 
recombinant plaques (blue coloured, occ-) were analyzed using PCR (see Figure 4-3). 
Figure 4-2
Recombination
Strategy
Procathepsin S geneORF1629 5´lacZ
PETLPPH
pBacBlue4.5
5´ORF1629 3´lacZ
Bac-N-BlueTM DNA 
1636 - 
1018 -
  839 bp
1453 bp
    MW           1               2 Figure 4-3    PCR analysis of recombinant viral clones
Samples  were  analyzed  for  the  recombinant  PCR  fragment 
(1453  bp)  encoding  human  procathepsin  S  and  its  mutants 
(Cys25→Ala/Ser), and the wild-type Bac-N-BlueΤΜ DNA PCR 
fragment (839 bp). DNA was isolated from the P-1 viral stocks 
and  used as template in PCR reactions with the recombinant 
baculovirus  forward  and  reverse  primers.  20  µl  from  each 
sample  were  analyzed  on  a  1% agarose  gel.  DNA was  also 
isolated from a wild-type plaque and used as a negative control. 
Lane 1: wildtype control. Lane 2: PCR sample using viral DNA 
from a pure recombinant plaque as template.
The identified pure recombinant low-scale P-1 virus stocks were amplified to the middle-scale 
P-2 and then subsequently amplified to the large-scale P-3 virus stocks. The first infection of 
HighFiveΤΜ insect cells (Invitrogen) with the virus stocks gave a successful expression of 
recombinant human procathepsin S and of the procathepsin Cys25→Ala/Ser mutants. The 
large scale expression was performed by Dr. G. Schmid from Hoffmann LaRoche in Basel 
(Switzerland). Initially, all virus stocks were tested for their expression rate in different insect 
cells (see Figure 4-4). 
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                   Sf9        Sf9       Sf9        Hi5        Hi5        Hi5
                   wt       C25A   C25S       wt       C25A     C25S
← ProCS
← CS
Figure 4-4 Western blot analysis of expressed human procathepsin S
The Western Blot shows the expression of human procathepsin S and mutants in different 
insect cells (Sf9, [Spodoptera frugiperda], and HighFiveTM, [Trichoplusia nigra]). The protein 
fractions were separated by SDS-PAGE under non-reducing conditions and blotted onto a 
nitrocellulose  membrane.  For  the  immunodetection  of  the  recombinant  procathepsin  S,  a 
rabbit polyclonal antibody against cathepsin S and its prodomain was used. All lanes show the 
precursor form (ProCS) and the mature enzyme form (CS). Protein fractions of the wildtype 
procathepsin S show additional intermediate products in form of double protein bands (red 
arrow).  
The  expression  of  recombinant  procathepsin  S  and  the  mutants  showed  no  significant 
difference in Sf9 cells and in HighFiveTM cells.  In all samples, low amounts of processed 
mature enzyme were found due to proteolytic activity of endogenous proteinases in the insect 
cells. Additional intermediate products in form of double protein bands were observed in the 
lane  of  the  wild-type  proenzymes  migrating  at  ~  28  kDa,  pointing  to  a  cleavage  in  the 
propeptide region by processed cathepsin S. The maturation of procathepsin S is interpreted 
as an intramolecular or intermolecular cleavage of the propeptide (Quraishi and Storer, 2001) 
but not understood in detail. 
4.1.1.3 Large-scale expression of the human procathepsin S Cys25→Ala mutant
The recombinant virus stock containing the gene encoding the procathepsin S Cys25→Ala 
mutant  was  used  for  the  large-scale  expression  (see  Methods)  in  order  to  eliminate 
autocatalytic processing of the protein. The concentration of the virus stock was determined 
using plaque assays, which revealed a MOI (multiplicity of infection) of 1-1.5 x 108 pfu/ml 
(plaque  forming  units/ml)  (G.  Schmid,  personal  communication).  The  substitution  of  the 
active-site cysteine with alanine resulted in a catalytically inactive protein that was unable to 
process  itself  to  the mature enzyme.  This way,  the loss of proenzyme during expression, 
purification  and  later  crystallization  by  unimolecular  degradation  was  avoided.  HighFive 
insect  cells  were used for  infection and expression since the growth of  these  cells  under 
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serum-free  conditions  facilitate  the  purification  of  recombinant  protein.  60  hours  after 
infection  the  released  recombinant  human  procathepsin  S  mutant  was  detected  in  the 
supernatant using SDS-PAGE and Western blot.  
Purification steps Yield of protein
  Mr       1        2
Supernatant of culture broth
(10 x concentrated)
 (Lane 1)
Affinity chromatography 
(ConA-Sepharose)
Concentration using Amicon 
MWL 10.000 (Lane 2)
 
345 mg in 500 ml
17.04 mg in 192 ml
14.79 mg in 9 ml
Mr       3
Gelfiltration chromatography
 Concentration using Centricon
MWL 5000 (Lane 3)
  C[Protein]: ≈ 7.0 mg/ml 
Figure 4-5   SDS-PAGE analysis of the purified human procathepsin S Cys25→Ala mutant.
SDS-PAGE was performed under denaturing conditions. 
The SDS-gels were stained with Coomassie Blue. 
Mr: standard. Red arrows mark the procathepsin S band. 
The protein concentrations were determined using the Bradford assay. 
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4.1.2 Purification of the recombinant human procathepsin S Cys25→Ala mutant
Procathepsin  S  is  glycosylated  at  the  position  Asn104p  in  the  propeptide,  enabling  the 
purification using affinity gel chromatography. Final purification of the recombinant human 
procathepsin  S  mutant  to  electrophoretic  homogeneity  was  achieved  using  gelfiltration 
chromatography  (see  Methods).  The  purification  of  500ml  10  times  concentrated  culture 
supernatant revealed  ∼ 1 % of the recombinant human procathepsin S Cys25→Ala mutant 
(see Figure 4-5). The protein was concentrated to 7.0 mg/ml in 0.1 M Tris ⋅ HCl, pH 7.4, 0.5 
M NaCl and stored in aliquots at -20°C. 
4.1.3  Bacterial expression and purification of the human cathepsin S propeptide
A glycerol stock of E.coli BL21 (DE3) cells (Novagen) transformed with the pASK75-hppCS 
expression plasmid was provided by G. Maubach. The plasmid DNA encoding the cathepsin 
S propeptide was isolated and checked by restriction analysis for size (see Figure 4-6), and 
sequenced  for  correct  amplification  and  ligation.  The  recombinant  human  cathepsin  S 
propeptide was expressed in  E. coli BL21 (DE3) and recovered from inclusion bodies (10 
mg/l bacterial culture) (see Methods). The purification (see Methods) using one gelfiltration 
step achieved a highly purified protein (see Figure 4-7), which was concentrated to 7.5 mg/ml 
in an acidic buffer containing 50mM sodium acetate (pH 4.5), 15 % acetonitrile. 
4072 bp -
3054 bp -
2036 bp -
1636 bp -
1018 bp -
506 bp -
396 bp -
344 bp -
298 bp -
Figure 4-6  (left)             
Restriction  analysis  of  pASK75-hppCS. 
After digestion with  XbaI and  HindIII, 2 
fragments were separated on a 1% agarose 
gel: the 3054 bp pASK75 vector fragment 
and  the  300  bp  insert  coding  for  the 
cathepsin S propeptide (red arrow).
Figure 4-7  (right)     
SDS-PAGE  analysis  of  purified  protein 
samples under denaturing conditions.  
The SDS gel was silver-stained. The red 
arrow  (right)  points  towards  the 
recombinant cathepsin S propeptide.
20 kDa - 
29 kDa -
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4.2 Crystallization and structure determination
4.2.1 The crystallization of the cathepsin S propeptide
4.2.1.1 Strategy
With a length of 99 amino acid residues (without N-terminal signal peptide) and a molecular 
weight of 11932 Da (Maubach et al. 1997) the propeptide of human cathepsin S is a small and 
hydrophobic protein. In sodium phosphate buffer (pH 6.5), the propeptide is in a folded state 
and only poorly soluble (~ 36µg/ml) (Maubach et al. 1997, Schilling et al. 2001, Pietschmann 
et al.  2002). The low solubility makes the cathepsin S propeptide unsuitable for structure 
determination  using  NMR as  well  as  for  crystallization.  To  circumvent  this  problem the 
protein was dissolved in an acidic buffer containing 50mM sodium acetate at pH 4.5  with 15 
% acetonitrile. At these conditions, the protein is unfolded or only partially folded due to a 
breakdown of the tertiary structure (Maubach et al., 1997, Schilling et al., 2001, Pietschmann 
et al., 2002). The dissolution in an acidic buffer supplemented with acetonitrile, allows the 
rise of the protein concentration. The protein was then subjected to crystallization screens, 
where the crystallization buffer should fulfill two important conditions:
1. A fast pH shift from acidic (pH 4.5) to nearly neutral conditions after mixing of the 
protein buffer and the crystallization buffer, rendering a switch from denaturing  to 
folding conditions.  The  pH shift  is  a  precondition  for  the  folding  process  of  the 
cathepsin S propeptide (Maubach et al. 1997).
2. The crystallization of the folded cathepsin S propeptide. In the crystallization assay, 
the pH shift allows the use of unsoluble protein in a high concentration, dissolved in a 
denaturing buffer without the formation of aggregates, precipitates, or other phases 
before equilibration with the crystallization buffer.
4.2.1.2 Crystallization using the hanging-drop vapor diffusion method
Using Crystal  Screens  I  and II  (Hampton Research),  crystallization buffers  were selected 
which allow such a pH shift. Only MES (2-morpholinoethanesulfonic acid) was found as a 
suitable buffer, and isopropanol as precipitant. A 2 µl hanging drop containing the protein 
solution was equilibrated with the same amount of crystallization solution containing 1.14 M 
MES (2-morpholinoethanesulfonic acid) at pH 6.75 and 10 % isopropanol (see Figure 4-8). 
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The mixture of crystallization solution with protein solution (50mM sodium acetate,  15% 
acetonitrile, pH 4.5) in a ratio of 1:1 gave a pH of ~ 6.7, indicating a probable fast pH shift 
within  in  the  droplet  after  mixing  the  two  different  solutions.  The  hanging  drops  were 
incubated at 4°C, 20°C and 30°C. Furthermore, protein, buffer, and precipitant were used in 
various concentrations in the crystallization assays.  
Figure 4-8 Crystallization strategy using the vapor diffusion method (hanging drop).
After mixing the crystallization buffer with the buffer containing the protein, a fast pH shift 
from 4.5 to nearly 6.7 in the hanging drop takes place. The concentration of the precipitant 
[ppt] in the reservoir is initially higher, usually about twice of that in the droplet, and the two 
reach a balance when the osmolarity of the drop becomes equal to that of the reservoir. This 
occurs  by  water  exchange from the  droplet  to  the  reservoir.  Here,  a  gradual  transfer  of 
isopropanol  from  the  reservoir  to  the  droplet  occurs  due  to  a  higher  vapor  pressure  of 
isopropanol compared to water.
The  variation  of  buffer  concentration  revealed  a  significant  influence  on  the  number  of 
crystals grown. Above 1.0 M MES, the appearance of crystals and their growth was observed, 
whereas below 1.0 M, many small crystals were observed in only a few droplets. The largest 
crystals were obtained at a MES-concentration of 1.14 M (see Table 4-1).
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Temperature
conc. of
MES (pH 6.75)
[M/l]
conc. of
isopropanol
[%]
conc. of
propeptide
[mg/ml]
Observations
4 °C 0.5 - 1.5 1 – 30 7.5 no crystals only precipitate
20°C 1.0 - 1.5 5 – 20 5 - 7.5 after 2 - 3 months:
• many small crystals, max. size 
of 20 x 20 x 10 µm
• no further growth
• formation of precipitate
30°C 1.0 - 1.5 10 5 - 7.5 after 4-5 days:
• many small crystals, max. size 
of 50 x 20 x 20 µm
• formation of precipitate
after 4 weeks:
• crystal growth to maximum size 
of 80 x 60 x 40 µm 
after 3 - 6 months:
• crystal growth to maximum size
of 100 x 70 x 50 µm
• decreasing mass of precipitate, 
in some drops precipitates 
disappeared
30° C 1.14 10 7.5 after 4-5 days:
• in some drops 10 - 15 crystals 
at maximum size of 50 x 20 x 
20 µm
• formation of precipitate
after 4 weeks:
• crystal growth to maximum size 
of 120 x 80 x 40 µm 
after 3 - 6 months:
• crystal growth to maximum size 
of 250 x 150 x 100 µm
• decreasing mass of precipitate, 
in some drops precipitates 
disappeared
Table 4-1 
Crystal growth statistics
The temperature seems to be very important for the growth of cathepsin S propeptide crystals. 
A crystallization at a temperature of 30°C resulted in an acceleration of crystal growth, and 
only a few crystals appeared in some droplets. These crystals grew faster than those observed 
at 20°C and reached a larger size. Furthermore, the appearance of precipitate was observed 1-
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2 days after setting up the droplets at all temperatures (see Table 4-1). In several droplets, the 
precipitate disappeared after several weeks or months. In that time, the crystals reached their 
maximal  size.  A  variation  of  the  concentration  of  the  precipitant  (+/−10%)  yielded  no 
improvement concerning number of crystals within the droplets, velocity of crystal growth, 
and  crystal  size.  In  droplets  set  up  without  isopropanol,  no  crystals  were  observed, 
independently of temperature, or concentration of protein or buffer. It was also possible to 
grow crystals using 10 % polyethylene glycole (PEG 8000) instead of isopropanol, but the 
crystals  reached  only  a  very  small  size.  The  pH  of  MES  plays  an  crucial  role  in  the 
crystallization of the propeptide. As expected, no crystals were observed below pH 6.75 of 
MES, indicating the importance of the pH shift from pH 4.5 to at least 6.5 for the folding of 
the propeptide molecules. Increasing of the pH to a maximum of 8.0 gave no improvement of 
the  crystals.  Alternatively,  unbuffered  ammonium sulfate  was  used  as  reservoir  solution, 
which will develop NH3 thus leading to a pH shift in the droplets. But growth of crystals 
could never be observed. Figures 4-9 and 4-10 give an impression of the crystals grown at 
30°C:
Figure 4-9: Drops with cathepsin S propeptide crystals in different numbers. 
Two selected drops containing cathepsin S propeptide crystals grown at the same conditions 
(30°C). Picture A represents a drop containing a high number of crystals grown within 2 - 6 
months. Picture B represents a drop containing only 4 crystals, which reached a bigger size 
than the crystals in the drop shown in picture A.
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After 4 - 5 days:
crystals with a maximum 
size of 50 x 20 x 20 µm
after 4 weeks:
crystals with a maximum
size of 100 x 80 x 40 µm 
After 3 – 6 months:
crystals with a maximum
size of 250 x 150 x 100 µm
Figure 4-10  Cathepsin S propeptide crystals. 
Apparently of tetragonal morphology, these crystals were grown in a buffer containing 
1.14 M MES (pH 6.75) + 10 % isopropanol at 30°C.
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4.2.1.3 Crystallization of the cathepsin S propeptide using the counter diffusion technique
In addition to the vapor diffusion method, crystallization was also undertaken in capillaries in 
order to improve cathepsin S propeptide crystals. J. M. Garcia-Ruiz has pioneered this method 
(Garcia-Ruiz & Moreno, 1994). Capillaries containing a protein-solution were stuck into a 
gel-precipitant reservoir and the crystal growth in the capillaries was observed. The crystals 
grew  all  along  the  capillary.  In  the  capillary,  a  near  continuum  of  growth  conditions 
developed,  caused  by  a  diffusion  of  gelled  crystallization  buffer  and  precipitant  into  the 
capillary. J. M. Garcia-Ruiz called this method gel acupuncture approach. A variant of this 
method is the counter diffusion technique, which has been developed for the crystallization in 
space.  Coupling between crystallization and diffusion is  achieved by using a box, named 
Granada Crystallization Box (GCB) (see Figure 4-11). 
Figure 4-11    Counter diffusion technique using the Granada Crystallization Box (GCB)
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The box was designed for the growth of protein crystals  inside capillaries with un-gelled 
precipitating  agent  by  the  counter  diffusion  technique  (Sauter  et  al.  2001).  The  counter- 
diffusion method requires the preparation of an agarose gel crystallization buffer mixture, 
which is filled into the bottom of the box. After insertion of the capillaries with the protein 
solution the gel is overlayed with the crystallization buffer containing 2 fold concentrated 
precipitant  (see  Figure  4-11).  Firstly,  the  precipitant  diffuses  into  the  gel.  When  the 
concentration of the precipitant in the gel and the overlaid buffer has reached an equilibrium, 
the  precipitant  will  further  diffuse  into  the  capillary.  The  method  allows  a  delay  of  the 
crystallization process.  The  delay  enables  the  transfer  of  crystallization assays  into space 
without premature crystallization events in the capillaries,  a  precondition for the study of 
protein crystallization under microgravity conditions. The crystallization experiments using 
the GCBs were carried out in the laboratory of Prof. JuanMa Garcia-Ruiz in Granada (Spain). 
• An agarose-crystallization buffer (1.14 MES, pH 6.75) mixture containing 1.5 % (w/v) 
agarose was heated to 80°C under continuous stirring. The mixture was boiled in order to 
break cross-links of the agarose fibers. When the solution had become transparent, boiling 
was continued for about two minutes. 
• The  agarose-buffer  solution  was  cooled  down  to  50°C.  5ml  of  the  solution  were 
transferred into each GCB and the gel was allowed to polymerize at room temperature.   
• Four Capillaries (0.3 mm diameter) with a length of 7 cm were filled with the protein 
solution (7.5mg/ml  purified  cathepsin  S  propeptide  in  50mM sodium acetate  + 15  % 
acetonitrile  at  pH 4.5).  Then the  upper  end of  the  capillary  was sealed with vacuum 
grease.  
• The  capillaries  were  pushed  into  the  gel  by  about  2-3  mm.  Finally,  5ml  of  the 
crystallization buffer containing 20% isopropanol were poured onto the gel layer. A cover 
was placed on the GCB and sealed with vacuum grease. 
• he  GCBs  (each  of  them  contained  2  capillaries)  were  incubated  at  20  and  30°C, 
respectively.
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After four weeks many tiny crystals have grown all along these capillaries, which had been 
incubated at 30°C. Precipitant has been formed in the capillary part inserted into the gel. After 
6 months, the crystals reached a size of nearly 50 µm in length.  After 1 year the largest 
crystals reached a size of nearly 150µm in length and 30 µm in width (see Figure 4-12). 
Pictures A, B, and C (Figure 4-12) show crystals, which were grown within the capillary. In 
the same GCB the crystals grown in a second capillary appeared of the same morphology but 
with additional edges (see pictures D, E, and F in Figure 4-13). No crystals were observed in 
these capillaries, which were incubated at 20°C. 
Figure 4-12   Cathepsin S propeptide crystals grown using the counter diffusion technique.
Crystals grown in capillaries using the counter diffusion technique, one year after incubation 
at 30°C. A, B, C show crystals with a maximum size of 100 x 100 x 30 µm. D, E, F show 
crystals in another capillary of the same GCB, with a maximum size of 150 x 120 x 30 µm. 
With respect to morphology, two slightly different crystal types were obtained. 
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4.2.1.4 Collection of diffraction data and processing (cathepsin S propeptide)
All crystals grown in hanging drops at a temperature of 30°C, had a minimal length of 100 
µm and diffracted to a maximum resolution of 7 - 6 Å at the in-house X-ray source (IMB 
Jena). At the synchrotron beamline, the crystals diffracted to a maximal resolution of 3.5 Å. 
The  crystals  were  flash-cooled  in  a  100  K  nitrogen  stream.  The  use  of  cryoprotectants 
(different oils)  did not improve the diffraction of the crystals.  Several  trials  with crystals 
mounted in capillaries revealed no improvement of the diffraction either. The crystals are 
tetragonal, with unit-cell dimensions  a =  b = 151.1 Å and  c = 75.8 Å. The unsatisfactory 
quality and low resolution of the collected data prevented the exact determination of the space 
group,  but  the  presence  of  two twofold  axes  in  addition  to  the  four-fold  axis  is  evident 
(P4x2y2). Two datasets were collected and processed, the data statistics of the best dataset is 
shown in Table 4-2. 
Cell parameters a =  b = 151.1 Å, c = 75.8 Å
Resolution range 30.0 – 3.50 Å
Number of observations 74 063
Number of unique reflections a 11482
Rmerge a 8.8 %  (44.5 %)
Rrim b 9.7 %  (49.4 %)
Rpim c 3.8 %  (19.0 %)
I/σ 11.8     (4.8)
Completeness of data 96.8 % (92.9 %)
Table 4-2   Data collection statistics for the cathepsin S propeptide
Statistics  of  data  (cathepsin S  propeptide crystal)  collected at  Synchrotron beamline X11 
(EMBL/DESY Hamburg), at a wavelength of 0.9101 Å. Values for the outermost resolution 
shell (3.63 - 3.50 Å) are shown in parantheses.
The crystals, which were grown by the counter diffusion technique diffracted to a maximum 
resolution of 4.5 -  5 Å at  the Joint IMB Jena-University of Hamburg-EMBL synchrotron 
beamline X13 at Deutsches Elektronen-Synchrotron, Hamburg, at a wavelength of 0.803 Å. 
They were also tetragonal with the same cell parameters. No data sets were collected due to 
the low diffraction resolution.
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4.2.1.5 Attempts to determine the structure of the cathepsin S propeptide
Several trials  with molecular replacement using AMoRe (Navaza,  1994) were carried out 
using  an  poly-alanine  model  of  the  propeptide  from  procathepsin  K  (PDB  entry  1BY8, 
LaLonde et al., 1999). After determination of the human procathepsin S Cys25→Ala mutant 
(this  work)  the propeptide  domain of  this  proenzyme was also  used  for  the  rotation and 
translation functions. Assuming 8 molecules per asymmetric unit the packing density was 2.3 
Å3/Da, which corresponds to approximately 45.7 % solvent in the crystal (see Table 4-3). This 
value is within the range found by Matthews (1968) for most protein crystals.
Monomers/A.U. Vm (Å3/Da) % solvent fraction
1 18.3 93.2
2 9.1 86.7
3 6.1 79.6
4 4.6 72.9
5 3.6 66.1
6 3.0 59.1
7 2.6 52.5
8 2.3 45.7
9 2.0 38.9
10 1.8 32.1
Table 4-3  Matthews coefficients for the cathepsin S propeptide
Matthews  coefficients  (Vm)  and  solvent  fraction  parameters  (cathepsin  S  propeptide), 
dependent on the number of monomers per asymmetric unit. The values in bold are assumed 
to be correct. Values correspond to the estimated copy number per a.u.. Calculations based on 
an asymmetric unit volume of 1.73 x 106 Å3 and an approximate mass for the monomer of 
11932 Da. 
The  molecular  replacement  approach  yielded  very  poor  solutions.  The  rotations  and 
translations gave correlation factors of ~ 0.20 and R factors of more than 60 %, independently 
of model and number of copies used in the calculations. After rigid body refinement using 
CNS (Brünger et al., 1998), electron-density maps were calculated but were not interpretable. 
The low resolution of the data and the high number of monomers in the asymmetric unit has 
not yet allowed phasing by molecular replacement. 
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4.2.2   Structure determination of the human procathepsin S Cys25→Ala mutant
4.2.2.1 Crystallization 
The human procathepsin S Cys25→Ala mutant was crystallized by using the hanging drop 
vapor  diffusion  method.  Crystals  were  obtained  by  equilibrating  2µl  7.0  mg/ml  protein 
solution with the same volume of reservoir solution (100mM  Tris ⋅ HCl, 200mM magnesium 
acetate, 20% polyethylene glycol 8000, final pH 7.5–7.8). Within 7 days at 20°C, platelet-
shaped crystals appeared and grew to a maximum size of 500 x 250 x 30 µm within the next 4 
weeks (see Figure 4-13).
Figure 4-13 Procathepsin S crystals.
Platelet-shaped crystals (maximum size of 500 
x 250 x 30 µm) of the human procathepsin S 
Cys25→Ala mutant grown in a hanging drop 
(vapor-diffusion method).
 Collection of diffraction data and processing
A full  dataset  to  2.1  Å resolution  was  collected  using  the  Joint  IMB Jena-University  of 
Hamburg-EMBL synchrotron beamline X13 at Deutsches Elektronen-Synchrotron, Hamburg, 
at a wavelength of 0.803 Å (X-ray diffraction pattern see Figure 4-14) (see  Methods). The 
space group was determined to be C2221, with unit cell dimensions a = 59.8 Å, b = 140.5 Å 
and  c = 78.6 Å. The asymmetric unit contained one molecule, corresponding to a packing 
density of 2.31 Å3/Da and a solvent content of ~ 47 % (Matthews, 1968).
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Figure 4-14   X-ray diffraction pattern of human procathepsin S crystal (Cys25→Ala)
                       at a resolution of 2.1 Å.    
Space group C 2 2 21
Cell parameters a = 59.8, b = 140.5, c = 78.6 Å
Resolution range 30.0 – 2.10 Å
Number of observations 283.005
Number of unique reflections a 19.350
Rmerge a 8.6 % (47.1 %)
Rrim b 9.5 % (53.6 %)
Rpim c 3.6 % (24.1 %)
I/σ 14.4 (3.0)
Completeness of data 97.9 % (93 %)
Table  4-4  Data  collection  statistics  for  the  human  procathepsin  S  Cys25→Ala 
mutantStatistics of data (cathepsin S propeptide crystal) collected at synchrotron beamline 
X13 (Joint IMB Jena-University of Hamburg-EMBL), at a wavelength of 0.803 Å. Values for 
the outermost resolution shell (2.14-2.10 Å) are shown in parentheses.
                                                                                                                                                   52
------------------------------------------------------------------------------------------------------------------Results
4.2.2.3 Structure determination and refinement
Molecular  replacement  was  carried  out  using  the  program AMoRe (Navaza,  1994),  with 
procathepsin  K  (LaLonde  et  al.,  1999)  as  a  search  model  (PDB entry  code  1BY8)  (see 
Methods).  The rotation function was calculated with reflections between 10 and 4 Å and 
yielded one solution with R = 52.5 % and a correlation coefficient of 16.7 %. The translation 
function also calculated with data between 10 and 4 Å gave a solution with R = 46.1 % and a 
correlation coefficient of 41.8 %. After rigid body refinement the R-value could be reduced to 
44.7 % with a correlation coefficient of 46.6 % (see Table 4-5).
Table 4-5
Molecular replacement statistics for the human procathepsin S Cys25→Ala mutant
Rotation Translation Rigid body fitting
α
β
γ
x
y
z
Correlation coefficient
R d
79.12
43.96
212.21  
0.00
0.00
0.00
5 %
52.5 %
79.12  
43.96
212.21
0.1794
0.0987
0.1809
41.8 %
46.1 %
78.41
42.95
213.55
0.1809
0.0829
0.0857
46.6 %
44.7 %
The  model  was  initially  refined  using  CNS  (Brünger  et  al.,  1998).  After  rigid  body 
refinement, simulated annealing, and energy minimization in torsion angle space, the R-value 
at 3.0 Å could be reduced to 0.35. The refinement was continued against the synchrotron data 
that had become available in the meantime. 5% of the unique reflections were set aside for the 
calculations of Rfree (Brünger, 1992). The R and Rfree for 30-2.1 Å resolution data was 0.227 
and 0.277, respectively. Several cycles of refinement, which at this stage consisted only of 
minimization  and  B-factor  optimization,  followed by  refitting  on  a  graphical  workstation 
using the program O (Jones et al., 1991), resulted in a model (see Figure 4-17) that contained 
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nearly all residues of the protein: residues 18p-107p, 114p of the prosegment (marked with 
the suffix p) and residues 1-217 of the mature cathepsin S. Residues 16p, 17p and 108p-113p 
are  missing  due  to  the  poorly  defined  electron  density.  After  introduction  of  242  water 
molecules the  R and Rfree   could be reduced to 19.8 % and 24.4 %, respectively. Refinement 
statistics are given in in Table 4-6.
Refinement
Resolution range 30.0 – 2.10 Å
Number of protein atoms 2459
Number of water molecules 242
Crystallographic R-factor 19.8 %
Rfree e 24.4 %
Rmsd (bonds) 0.009 Å
Rmsd (angles) 1.35°
Average B-factor 27.6 Å2
Table 4-6
Refinement statistics for the human procathepsin S Cys25→Ala mutant  
4.2.2.4 Quality of the structure model
The asymmetric unit contains one molecule. The r.m.s. deviation of bond lengths and angles 
of the structure are 0.009 Å and 1.35° respectively, suggesting good chemical geometry. A 
Ramachandran plot (Ramachandran and Sasisekharan, 1968) (see  Methods) gave 86.1% of 
residues in the most favoured region and 13.5% of the residues in the additional allowed 
regions. No residues were found in the disallowed region, and only one residue (Thr106p) 
was found in the generously allowed region (see Figure 4-15). The residues of the published 
sequence (Shi et al., 1992, Wiederanders et al., 1992) fit well into the electron density, with 
the exception of a few residues in the solvent exposed C-terminal region of the prodomain 
(Lys108p – Arg113p) as well as the residues Ala 16p and Gln 17p at the N-terminus (see 
Figure 4-16). Residues Lys108p - Arg113p were not built into the poorly defined electron 
density. Continous density was observed in Fo - Fc maps at 0.6 sigma, but this is far below 
noise level for an Fo - Fc map. A cleavage within this region can be excluded. In the samples 
of the purified procathepsin S protein checked by SDS-PAGE under denaturing conditions, 
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additional protein bands, which might be due to a cleavage of the propeptide domains of 
cathepsin S have never been observed.
Figure 4-15
Ramachandran plot for the 2.1 Å structure of the human procathepsin S Cys25→Ala mutant.
Plot statistics
Residues in most favoured regions [A, B, L]
Residues in additional allowed regions [a, b, l, p]
Residues in generously allowed regions [∼a, ∼b, ∼l, ∼p]
Residues in disallowed regions
Number of non-glycine and non-proline residues
Number of end-residues (excl. Gly and Pro)
Number of glycine residues (shown as triangles)
Number of proline residues
Total number of residues
230
  36
    1
    0
267
    4
  27
  10
308
86.1 %
13.5 %
 0.4 %
 0,0 %
100 %
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Figure 4-16 Overall structure of the human procathepsin S Cys25→Ala mutant. 
The molecule consists of 97 residues of the propeptide (red) and 217 residues of the mature 
enzyme (turquois). The dashed line marks the 6 residues at the end of the C-terminal part of the 
propeptide  missing  due  to  poorly  defined  electron  density.  The  C-terminus  of  the  mature 
enzyme (Ile217) and the Ala25 in the active site are labeled. Picture drawn with Molscript 
(Kraulis, 1991).
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4.2.3  The structure of the human procathepsin S Cys25→Ala mutant  
4.2.3.1 Overall description  
The molecule of procathepsin S consists of 114 residues of the proregion (marked with “p” in 
Figure 4-17) and 217 residues of the mature enzyme (Figure 4-17). The signal peptide (1p – 
15p) has been cleaved off, so that the numbering of  the propeptide starts with the first N-
terminal residue Ala 16p of the proenzyme. The propeptide contains an N-terminal globular 
domain, which consists of three α-helices (α1p-α3p) and a β-strand (β1p). These interact with 
the prosegment-binding loop (PBL), which is an omega-loop of the enzyme domain. A 310-
helix (3101p) is formed between helix α3p and strand β1p. 
Figure 4-17 Stereo picture of the human procathepsin S Cys25→Ala mutant structure
The propeptide domain is coloured in red and the mature enzyme in grey. Residues of active 
site (Cys25→Ala25, His164, Asn184) are highlighted in blue. The regions including the 310-
helix (3101p) and the β-strand (β1p) underlaid in light blue. The picture was prepared with the 
program Swiss-PdbViewer (Guex & Peitsch, 1997).
Being homologous to all members of the papain-like proteinases, the mature enzyme consists 
of two domains, referred to as L (left) and R (right) (see Figure 4-19), which between them 
form the V-shaped active-site cleft. The overall fold of human procathepsin S is similar to the 
structures determined for other members of the L-like cathepsins such as human procathepsin 
K and L (LaLonde et al., 1999, Coulombe et al., 1996) as well as to procaricain (Groves et 
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al., 1996). The superposition of procathepsin S with procathepsin K, L and B (PDB entries 
1BY8, 1CS8 and 3PBH) gave an RMSD of  0.79, 0.88 and 1.62 Å for 278, 277 and 246 Cα 
atoms as target pairs (see Figure 4-19). The high RMSD between procathepsin S and B can be 
explained by structural differences in the globular domain of the propeptide (see Figure 4-18). 
Furthermore,  the  additional  occluding-loop of  the  mature  cathepsin  B  structure,  a 
characteristic structural element of this enzyme, influences the RMSD of the superposition 
with both L-type cathepsins. 
 
Figure 4-18 Superimposed procathepsin structures.
Stereo picture of superimposed structures of procathepsin S (black), K (red), L (yellow), and 
B (green) (PDB entries 1BY8, 1CS8, 3PBH). The picture was prepared with the program 
Swiss-PdbViewer (Guex & Peitsch, 1997).
The human procathepsin S Cys25→Ala mutant was crystallized as a glycosylated protein. At 
Asn104p in the propeptide region, the electron density is characteristic for N-glycosylation 
but its quality does not allow to model-build the carbohydrate. The overall B-factor for the 
structure is 27.6  Å2. In general, the B-factors for propeptides of all cathepsins are larger than 
those for their cognate enzyme domains due to the highly flexible C-terminal segment of the 
propeptide. The average B-factor for the propeptide of human procathepsin S mutant is 29.6 
Å2,  only  slightly  higher  than  for  mature  cathepsin  S,  27.0  Å2.  This  can  be  additionally 
explained by the lack of information for the residues 108p – 113p in the C-terminus of the 
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propeptide where larger B-factors can be assumed. The human procathepsin S Cys25→Ala 
mutant will be subsequently referred to as procathepsin S for the reason of simplificity.
4.2.3.2 The enzyme domains of procathepsin S
The structure shows that the overall  fold of the enzyme domains (mature cathepsin S) is 
similar to that of other cathepsins but reveals significant differences in the active site cavity. 
The  greatest  structural  similarity  between  cathepsin  S  and  other  homologous  cysteine 
proteinases with known three dimensional structures is  seen with the enzyme domains of 
procathepsin K and L (PDB entries 1BY8 and 1CS8). 
Figure 4-19 View of superimposed mature cathepsin structures. 
The Cα-trace of the enzyme domains of procathepsin S (this work) is coloured in blue, of 
procathepsin K (PDB entry 1BY8) in green, and of procathepsin L in red (PDB entry 1CS8). 
The amino acid residues of the catalytic triade of cathepsin S are shown. The R-domain and 
the L-domain are  marked with R and L and underlaid by a  transparent  background.  The 
picture was prepared with the program Swiss-PdbViewer (Guex & Peitsch, 1997).
Superposition of the structures of mature cathepsin S, K and L gives an RMSD of 0.61 Å with 
211 and 205 Cα atoms as target pairs for both molecules (see Figure 4-19). The most evident 
backbone differences between the enzyme domains are confined to surface loops, and do not 
involve residues of the active-site cavity. Three disulfide bridges (Cys22 – Cys66, Cys56 – 
Cys99,  Cys158  –  Cys206)  are  formed  in  procathepsin  S,  which  are  equivalent  to  those 
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observed in in cathepsins L, K, porcine H (Guncar et al., 1998), B (Podobnik et al., 1997), V 
(Somoza et al., 2000) and papain (Kamphuis  et al., 1984). The active-site cavity contains a 
catalytic triad consisting of Cys25 (substituted by an alanine in the procathepsin S mutant), 
His164 and Asn184, which are in nearly the same position as the active site residues of all 
known cysteine proteinase structures belonging to the cathepsins. The crystal structure of a 
cathepsin S Cys25→Ser mutant (Turkenburg et al., 2002) is virtually identical to the enzyme 
domains, mentioned above. The description of the active site, including the substrate-binding 
sites for substrate residues P1, P2, and P3 (Schechter & Berger, 1967) of the cathepsin S 
Cys25→Ser mutant is similar to what is found in the procathepsin S Cys25→Ala mutant. The 
comparison of both active sites gave no significant difference with regard to the orientation of 
the active-site residues (see Figure 4-20).
Figure 4-20
Active site residues of cathepsin S.
Superimposed  amino-acid  residues  of  the 
cathepsin S active-site. The residues of the 
procathepsin  S  Cys25→Ala  mutant  (this 
work) are coloured in red, the residues of 
the mature cathepsin S Cys25→Ser mutant 
(PDB entry  1GLO) in  green.  The  2Fo-Fc 
electron density map for procathepsin S is 
contoured at the level of 1σ (magenta). The 
picture  was  prepared  using  the  program 
Swiss-PdbViewer (Guex & Peitsch, 1997).
Only  the  orientation  of  some  residues  close  to  the  substrate  binding  site  differ  due  to 
interactions between the enzyme domains and the propeptide, which is missing in the crystal 
structure of the mature cathepsin S Cys25→Ser mutant. Structural details about the active site 
cavity and the substrate-binding sites are described under 4.2.3.6 - 8.
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4.2.3.3 Overall description of the propeptide
The N-terminal segment of the propeptide (Figure 4-18) forms a globular domain comprising 
three α-helices (α1p = 25p-35p, α2p = 44p-68p, α3p = 85p-92p) and a β-strand (β1p = 72p-
76p). A 310-helix (3101p = 79p-82p) is found between β1p and α3p instead of a loop in the 
propeptide region of procathepsin K, L, B and procaricain. A different orientation of helix α
3p in comparison with the corresponding helices in the propeptides of  K and L was found. 
The superimposed propeptide structures (see Figure 4-21) reveal that the  α3p-helix in the 
propeptide of procathepsin S is positioned in nearly the same orientation as the corresponding 
helix in the propeptide of procathepsin B.
                           
                           Figure 4-21
Superimposed cathepsin propeptides.
Stereo  picture  of  superimposed  α3p-
helices of cathepsin propeptides. S (blue) 
(this  work),  K (grey),  L  (green),  and B 
(red)  (PDB  entries  1BY8,  1CS8  and 
3PBH). The picture was prepared with the 
program  Swiss-PdbViewer  (Guex  & 
Peitsch, 1997).
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4.2.3.4 The globular domain of the propeptide
The helices  α1p and  α2p are connected by a loop of seven residues. They intersect at an 
angle of ~ 90° and are tightly packed against one another, thereby forming a hydrophobic 
core,  which is  comprised of the side chains of  Leu24p,  Trp28p,  Trp31p, Ile51p,  Trp52p, 
Leu56p, Met77p and the aliphatic part of Glu53p. The three aromatic rings of Trp28p, Trp31p 
and Trp52p are positioned perpendicular to each other and form the center of the hydrophobic 
core (Figure 4-24). Additional interactions between the two helices such as hydrogen bonds 
and salt bridges contribute to the stabilisation of the N-terminal globular domain (Table 4-7). 
A small number of these interactions are involved in the contact of the two helices to the α3p-
helix. From the end of helix α2p, the chain turns four residues back, forms a hairpin structure 
and  follows  along  this  helix  as  an  antiparallel  β-strand  (β1p  =  72p-76p).  The  interface 
between helix α2p and strand β1p is formed by the hydrophobic portions of the side chains of 
Val59p, Asn63p, and Leu75p. Following the β-strand, the backbone forms a 310 -helix (3101p 
= 79p-82p), which is capped by an N-terminal Asn-loop forming a hydrogen bond to the 
backbone of Leu80p (Asn79pOD1··· Leu 80pN (2.79 Å)) (see Figure 4-22). This region seems to 
be composed of two type III ß-turns arranged in tandem. Such turns were first identified by 
Venkatachalam  (1968)  who  found  three  types  (I-III)  each  containing  a  hydrogen  bond 
between the carbonyl oxygen of residue i and the amide nitrogen of i+3 as formed in the 
cathepsin S propeptide (Asn78p-Gly81p, Leu80p-Met83p, see Figure 4-23). Both type III ß-
turns might be part  of a 310-helix. By using the programs PROCHECK (Laskowski  et al. 
1993) and DSSP (Kabsch & Sander, 1983) the  φ and  ψ angles for the conserved residues 
His79p,  Leu80p,  Gly81p,  and Asp82 were proven to  be located in  the sterically  allowed 
regions for this helix. The 310-helix is not a common secondary structural element in proteins. 
Only 3.4% of  all  residues are  involved in 310-helices in the Kabsch and Sander database 
(1983), and nearly all of these are located helical segments containing 1-3 hydrogen bonds. α-
Helices sometimes begin or end with a single turn of a 310-helix (one hydrogen bond).
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Figure 4-22  Stereo picture of the 310-helix (3101p) within the propeptide.
Residue His79p is not shown. The helix is stabilized by a N-terminal Asn-loop (hydrogen 
bond OE1Asn78p··NLeu80p). The 2Fo-Fc electron density map (turqois) is contoured at a level of 1
σ. Hydrogen bonds are indicated as dashed lines.The atoms are coloured blue (N), red (O), 
grey (C), and yellow (S), respectively. The picture was prepared with the program Swiss-
PdbViewer (Guex & Peitsch, 1997).
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The protein sequence of the proregion between Asn78p at the N-terminus of  helix  3101p and 
Val88p within helix  α3p is similar to the corresponding proregions of cathepsin K and L. 
Helix α3p of the cathepsin S propeptide is rotated 20° counter-clockwise compared to the 
helices of  K and L, and is rotated 10° clockwise compared to the corresponding helix in the 
cathepsin B proregion (Figure 4-23). In contrast to the corresponding propeptide helices of 
procathepsin K, L, and B, the differently oriented helix  α3p seems to be extended by the 
residues Ser93p and Ser94p. The different orientation of  helix  α3p can be described by a 
rotation along the helix axis towards the L-domain. Beyond Ser94p, the propeptide emerges 
from the surface of the protein and follows along the groove through the two domains of 
cathepsin S.
Figure  4-23  Stereo  picture  of  superimposed  α3p  helices  of  cathepsin  S-,  K-,  and  B-
propeptides  (PDB entries  1BY8,  3PBH).  The  residues  of  the  cathepsin  S  α3p  helix  are 
coloured in grey, the helices of B (black) and K (red) are drawn as Cα backbones. The 2Fo-Fc 
electron density map is contoured at a level of 1σ (tourquois). The picture was prepared with 
the program Swiss-PdbViewer (Guex & Peitsch, 1997).
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4.2.3.5 Stabilization of the globular propeptide domain
The stabilization of the globular domain of L-cathepsin propeptides and the role of conserved 
residues contributing to the stability by hydrogen bonds and salt bridges have been discussed 
extensively  in  previous  structural  studies  (Coulombe  et  al.  1996;  Groves  et  al.  1996, 
Sivaraman et al. 1999). Especially electrostatic interactions (salt bridges) are likely to play a 
significant role in the stabilization of the globular structure (see Table 4-7). In procathepsin S, 
several clusters of salt bridges are formed within the helical parts of the propeptide. Glu44p 
and Arg48p,  which  contribute  to  the  formation  of  such  interactions  are  belonging to  the 
conserved  ER(F/W)N(I/V)N-motif  (Karrer  et  al.,  1993)  and  are  located  in  the  second 
propeptide α-helix (α2p) (see Figure 4-24). 
Table 4-7  Stabilizing salt bridges and hydrogen bonds within the propeptide
Atom Distance (Å) Atom Distance (Å) Atom Distance (Å) Atom
Asp21pN 2.7 Glu53pOE1
Asp21pO 2.8 Arg49pNH2
Asp25pOD1 2.8 Arg49pNH1
Trp28pNE1 2.8 Glu45pOE2
Lys32pNZ 2.9 Glu45pOE2
Tyr39pOH 2.6 Asp82pOD1 3.4 Lys37pNZ 3.2   Asp82pOD2
Arg48pNH2 3.2 Glu44pOE1 3.0   Arg48pNE
Arg49pNE 2.9 Glu53pOE1 3.1 Arg49pNH2
Asn55pND2 2.9 Gly81pO
Asn63pOD1 2.9 Leu75pN
Asn63pND2 2.8 Leu75pO
Glu65pOE1 2.6 His71pNE2
His79pO 2.8 Lys37pNZ
Glu87pOE1 2.8 Arg48pNH1
Glu87pOE1 2.8 Arg48pNH2
Conserved residues belonging to the ER(F/W)N(I/V)N -motif are labeled in blue.
Salt bridges are underlaid in red.
Instead of Glu44p and Val59p, an aspartate (Asp27p) and an isoleucine (Ile42p) are located at 
the same position in the propeptides of cathepsins K and L. Apart  from salt  bridges and 
hydrogen  bonds,  hydrophobic  interactions  contribute  greatly  to  the  stabilization  of  the 
globular  propeptide  domain. The  conserved  amino-acid  residues  within  the  globular 
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propeptide  domain  were  interesting  targets  for  mutation  studies  in  which  some  of  these 
residues were replaced by amino acids with small side chains such as alanines (Kreusch et al., 
2000, Schilling et al. 2001, Pietschmann et al., 2002). The consequences of the mutations on 
folding, transport, targeting and maturation of the cathepsin precursor are discussed below in 
view of the location and orientation of the mutated residues (see Discussion).
Figure 4-24 View of the conserved residues within the propeptide. 
Overview of the conserved residues involved in stabilization of the globular domain of the 
cathepsin S propeptide. Residues belonging to the ER(F/W)N(I/V)N motif are labeled in red. 
Dashed lines mark hydrogen bonds. The residues of the PBL (propeptide binding loop) are 
coloured in blue, and residues of the propeptide interacting with the PBL are coloured in 
green.  The  calculation  of  the  contact  surface  between the  bottom side  of  the  propeptide 
(green) and the upper side of the PBL (blue) as well as the picture preparation were carried 
out with the program Swiss-PdbViewer (Guex & Peitsch, 1997).    
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4.2.3.6 Anchoring of the propeptide onto the enzyme domains
The propeptide of  cathepsin S contacts with the cognate enzyme via an extended area which 
can be subdivided into three adjacent areas: a large omega loop on the surface of the enzyme, 
referred to as the propeptide binding loop (PBL), a hydrophobic groove leading to the S´ 
subsites of the active site and the S1-S3 sites of the substrate-binding site. Along these contact 
areas the propeptide embraces the enzyme like a clamp and thereby covers the active site in a 
direction reverse to the substrate. 
The PBL (Figure 4-24 and 4-25) of cathepsin S consists of  the residues Arg141 - Tyr153, and 
the main contact between the propeptide and the PBL involves the residues of  the β1p strand, 
forming a two stranded β-sheet with Arg149 - Val152. Additional hydrophobic and van der 
Waals contacts are formed between Phe58p, Val59p, Tyr73p and Leu75p and a cluster of 
hydrophobic amino acid residues within the PBL, including Leu147, Tyr148 and Tyr153. 
This cluster is extended by aromatic residues, such as Phe145, Phe190, Trp186 and His164, 
with the latter two being part of the active site. With the exception of some residues, a similar 
cluster arrangement can be found in procathepsins S, L and K. 
Four side chains from the propeptide helix 3101p and helix  α3p, namely Asn78p, Leu80p, 
Met83p and Leu91p (α3p), are sticking into the vicinity of the active site and extend the 
hydrophobic cluster of the S´-site groove. 
The side chain of Met83p points towards the side chain of Phe146. A C-H⋅⋅⋅pi interaction 
between  Met83pCE as  H-donor  and  the  aromatic  ring  (pi-system)  of  Phe146  as  acceptor 
(Met83pCE - Phe146pi distance = 3.88 Å and ρMet83pCEH - Phe146pix = 125.92°) (see Figure 4-
25) could be identified by using programs written by M. Brandl (Brandl et al., 2001) as well 
as by D. Pal (see Methods). Such interactions, which were first discovered in proteins in the 
mid 1990s, (Derewenda et al., 1995) can be described as weakly polar interactions (Burley & 
Petsko,  1988),  but  they  can  also  be  classified  as  hydrogen  bonds,  although  they  are 
considerably weaker than `classical H-bonds´ (Weiss  et al., 2001). Their functional role in 
folding and stabilization of proteins remains unclear, but investigations in this direction seem 
to be useful because of the frequent occurence of these interactions in proteins (Weiss et al., 
2001). The interaction between Met83p and Phe146 found in procathepsin S is unique within 
the L-like cathepsin family.  A superposition of the propeptides of cathepsins S,  K and L 
revealed that the Met83p side chain gets close to the position of the side chains of Phe71p 
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(helix  α3p  of  the  cathepsin  L  propeptide)  and  Val71p  (helix  α3p  of  the  cathepsin  K 
propeptide), which also extend into the S´-groove (Figure 4-26). The equivalent methionines 
in the propeptides of cathepsin K and L are therefore directed rather to the outer surface of the 
propeptides. The position of Phe146 is occupied by a leucine in cathepsin L and a glutamine 
in cathepsin K. The superposition of the structures of the procathepsin S Cys25→Ala mutant 
(this work) and of the mature cathepsin S Cys25→Ser mutant (PDB entry 1GLO, Turkenburg 
et al.  2002) reveales a different orientation of Phe146. In the structure of the  cathepsin S 
Cys25→Ser  mutant,  Phe146  is  directed  towards  the  solvent.  In  the  structure  of  the 
procathepsin S  Cys25→Ala mutant, the aromatic ring of Phe146 points towards the active-
site cavity interacting with Met83p of the propeptide (see Figure 4-25). 
Figure 4-25  View of the interactions between cathepsin S propeptide and PBL (propeptide 
binding  loop).  PBL:  Arg141-Tyr153.  Labels  of  residues  belonging  to  the  propeptide  are 
marked with “p”. Phe146 of the superimposed mature cathepsin S Cys25→Ser mutant (PDB 
entry 1GLO, Turkenburg  et al., 2002) is coloured and labeled in red. Atoms are shown in 
grey (C), red (O), blue (N), and yellow (S). The dashed line marks a C-H⋅⋅⋅pi  interaction. The 
2Fo-Fc electron density for Met83p and Phe146 is contoured at a level of 1σ (coloured in 
turquois). The  picture was prepared with the program Swiss-PdbViewer  (Guex & Peitsch, 
1997).
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Figure 4-26 Superimposed cathepsin propeptides around the active-site.
View of the different oriented propeptides of cathepsins S (grey; this work), K (red; PDB 
entry 1BY8), and L (green; PDB entry 1CS8) around the active-site and, partially, the PBL. 
PBL:  cathepsin  S:  Arg141-Leu147,  cathepsin  K:  Ser138-Phe144,  cathepsin  L:  Gly139-
Phe145. 
Stereo picture A shows the superimposed α3p helices of the cathepsin S- and K propeptides, 
PBL and the active site histidine. 
Stereo picture B shows the same parts of the procathepsin S structure superimposed with the 
corresponding residues of procathepsin L.
The pictures were prepared with the program Swiss-PdbViewer (Guex & Peitsch, 1997).
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4.2.3.7 Interactions between helix α3p and the S´- subsites
Regarding the  α3p helices of the superimposed procathepsins, the helix of procathepsin S 
adopts a position intermediate between the corresponding helices of procathepsins B, L and 
K. In procathepsin S, this leads to larger distances between residues of the hydrophobic face 
of helix α3p and the S´subsites of cathepsin S than found in procathepsins L and K. Helix α
3p  (Figure  4-26  and  4-27)  interacts  with  the  hydrophobic  surface  of  the  hydrophobic  S
´-groove via the residues Val88p, Ser90p, Leu91p and Thr92p, the side chains of which point 
to the PBL (Arg141 - Phe146p) as well as to the region between Gln19 and Ala24 of the L-
domain. In particular, Leu91p is extending into the centre of the hydrophobic groove and 
forms van der Waals contacts to Trp186 and Met83p. The side chains of Val88p and Thr92p 
line the right side of the helix, which is directed towards the PBL (see Figure 4-28). They 
extend nearly parallel to each other towards the residues Arg141 - Phe146 of the PBL and 
form a van der Waals contact with the hydrophobic part of Arg141 and Phe146, respectively. 
On the left side of the helix, the side chain of Ser90p points towards the L-domain, forming a 
van der Waals contact with Gly23. A cavity was detected between the PBL and the right side 
of the last helix turn, below Leu91p and Thr92p. This cavity is positioned in the S´1 pocket, 
which comprised by Ala140, Arg141, Trp186 and the active site residue His164, and is filled 
with one water molecule (Figure 4-27). This water molecule is positioned between Thr92p (α
3p), Arg141 (S´1) and Asn163, interacting with these residues by hydrogen bonds. In the 
structures of procathepsins K and L no water molecules were detected between the equivalent 
propeptide helix  α3p and the PBL (LaLonde  et al.,  1999, Coulombe  et al.,  1996). In the 
center of the active site, between Gln19, His164 and Ser94p (α3p), a second water molecule 
was detected, forming hydrogen bonds between active-site residues and the propeptide. In the 
C-terminal  region of the propeptide,  some residues interact  with aromatic  residues of the 
enzyme domains leading to a close contact of this flexible region with the surface of the 
mature enzyme molecule. These interactions are described below.
4.2.3.8 Interactions within the S subsites
The propeptides of cathepsin K and L follow the S subsites in an extended conformation, 
whereby Gly77p is located closest to the active site cysteine. The propeptide of cathepsin S 
forms an additional loop in this region, elongating helix α3p (Figure 4-27). At the end of this 
loop, Ser94p is oriented toward the mutated Cys25→Ala, forming a weak hydrogen bond 
(Ser94pOGΕΕΕ Ala25N (3.4  Å)).  In  comparison  with  Gly77p  of  the  cathepsin  K-  and  L 
                                                                                                                                                   70
------------------------------------------------------------------------------------------------------------------Results
propeptides the distance of Ser94p to the active site residues is somewhat larger. Glycine 
allows for a close approach to the active-site nucleophile, and thus permittes these propeptide 
regions to reach the bottom of the cleft. The water molecule between the C-terminal part of 
the  α3p helix and the active-site residues of procathepsin S (see above) may additionally 
influence the distance between the helix and the active site. Furthermore, the side chain of 
Ser94p is in contact with the oxyanion hole, forming a very weak hydrogen bond (3.7 Å)  to 
NE1 of Gln19. The previously described S subsites (McGrath et al., 1998; Turkenburg et al., 
2002) are occupied by residues C-terminal to helix α3p. Located in the C-terminal loop below 
the helix, Ser94p occupies the S1 pocket, which is comprised of the main-chain atoms of 
Asn64, Gly65, Cys66, Asn67, Gly68 and Gly23. These residues form van der Waals contacts 
to the side- and main chain atoms of Ser93p and Ser94p. Leu95p is extending into the S2 
pocket, which comprises Met71, Gly137, Val138, Gly165, Val167 and Phe211.
Figure 4-27   Propeptide of procathepsin S in the vicinity of the active site. 
Propeptide of procathepsin S in the vicinity of the active site. Residues belonging to S1´ are 
shown in yellow, to S1 in red, to S2 in blue, and to S3 in green. Atoms of the propeptide are 
displayed in grey. Two water molecules in the active site cavity are shown in blue. Hydrogen 
bonds are  marked as dashed lines  (red).  Phe146 and Phe70 of  the superimposed mature 
cathepsin S Cys25→Ser mutant (PDB entry 1GLO, Turkenburg et al., 2002) are colored and 
labeled in black. Residues involved in C-H⋅⋅⋅pi interactions are colored and labeled in black. 
Labels of residues belonging to the propeptide are marked with “p”. Hydrogen bonds and C-
H⋅⋅⋅pi interactions are marked as dashed lines (red).  The stereo picture was prepared with the 
program Swiss-PdbViewer (Guex & Peitsch, 1997).
                                                                                                                                                   71
------------------------------------------------------------------------------------------------------------------Results
A leucine is also preferred in the S2 subsite of  procathepsin K, and in procathepsin L a 
phenylalanine occupies the same subsite. Mainly large side chains, such as those of glutamine 
(procathepsin L), lysine (procathepsin K) or, especially in procathepsin S, Arg96p extend into 
the S3 pocket,  which in cathepsin S comprises Gly62, Asn63, Lys64, Gly68, Gly69, and 
Phe70. A cathepsin S - specific loop containing the residues 61 - 64 shapes the back of the S3 
pocket and limit  the subsite to a smaller  size than formed in cathepsin K. Below the S3 
pocket, Pro98p of the propeptide forms a C-H⋅⋅⋅pi bond with Phe70 (Pro98pCD as H-donator 
and the aromatic ring of Phe70 as acceptor;  Pro98pCD −  Phe70pi distance = 3.64 Å and  ρ 
Pro98pCDH - Phe70pix = 122.93°); identified with programs written by M. Brandl and D. Pal. A 
superposition of the mature cathepsin S Cys25→Ser mutant (PDB entry 1GLO, Turkenburg 
et  al.  2002)  with  the  procathepsin  S  Cys25→Ala  mutant  revealed  an  orientation  of  the 
corresponding Phe70 away from the domain towards the solvent (see Figure 4-28).
Figure 4-28 C-H⋅⋅⋅pi interaction between Pro98p and Phe70.
View  of  the  propeptide  residue  Pro98p  interacting  with 
Phe70 of the enzyme domain. Labels of residues belonging 
to the propeptide are marked with “p”. 
Phe70 of the superimposed mature cathepsin S Cys25→Ser 
mutant  (PDB  entry  1GLO,  Turkenburg  et  al.,  2002)  is 
coloured and labeled in red. Atoms are shown in grey (C), 
red  (O),  and  blue  (N).  The  dashed  line  marks  a  C-H⋅⋅⋅pi 
interaction.  The  2Fo-Fc electron  density  is  contoured  at  a 
level of 1σ (turquois).  The  picture was prepared with the 
program Swiss-PdbViewer (Guex & Peitsch, 1997).
4.2.3.9 Electrostatic potential
The pI for the human procathepsin S Cys25→Ala mutant is 8.43.  The mature cathepsin S 
molecule  is  nearly  neutrally  charged  with  a  pI  of  7.64,  and  the  pI  of  the  cathepsin  S 
propeptide  is  9.26,  calculated  for  the  protein  sequence  without  the  signal  peptide  (see 
Methods). In order to compare the interactions between enzyme domains and propeptides or 
substrates,  the  focus  was on a  comparison of  the electrostatic  potentials  of  the cathepsin 
enzyme domains and the propeptides. Based on the protein sequences of known cathepsin 
structures including cathepsin S and papain, the pIs of their propeptides were calculated: they 
all range between 9 and 9.8 (see Table 4-8). Only the calculated pIs for the propeptides of 
papain (4.62) and cathepsin K (6.32) differ strikingly from the values found for the other 
cathepsin propeptides. An assessment of the electrostatic potential of all cathepsin propeptides 
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with regard to function is difficult,  because the propeptides differ in length and structure. 
Furthermore, the structures of several precursors, such as of human cathepsin H, F, and V, are 
not known. 
Enzyme pI mature pI propeptide
Papain 8.88 4.62
Cathepsin S 7.64 9.26
Cathepsin K 8.29 6.32
Cathepsin L 4.43 9.00
Cathepsin V
Cathepsin B
8.59
5.23
9.56
9.56
Cathepsin H 5.93 9.76
Cathepsin F 5.82 9.43
Cathepsin  X 5.48 9.77
Table 4-8   Isoelectric points of cathepsins. 
The  isoelectric  points  (pI)  were  calculated 
independently  for  each  protein  sequence  of 
the  mature  enzyme  and  for  the  propeptide 
without  the  N-terminal  signal  peptide 
sequence.  The  calculations  were  carried  out 
with  COMPUTE  pI/MW  (Wilkins  et  al., 
1998). The L-like cathepsins are coloured in 
red.
The structural similarity between the propeptides of the L-like cathepsins L, K, and S allows a 
correlation of the structure and electrostatic potential on their surfaces. This might elucidate 
aspects such as pH-dependent folding of the propeptides and their  selectivity towards the 
cognate enzymes. Figure 4-29 shows the different electrostatic potentials for the molecular 
surfaces of the cathepsin K, L, and S propeptides. In comparison with the propeptides of 
cathepsin S and L, the cathepsin K propeptide shows more negatively charged areas on the 
surface, especially on the top of helix α1p, furthermore along the hairpin structure at the end 
of helix  α2p, and of helix  α3p facing the PBL. On the surfaces of the cathepsin S and L 
propeptides more positively charged regions are detected. Figure 4-29 shows the different 
electrostatic potentials for the molecular surfaces of the cathepsin K, L, and S propeptides. In 
comparison with the propeptides of cathepsin S and L, the cathepsin K propeptide shows 
more negatively charged areas on the surface, especially on the top of helix α1p, furthermore 
along the hairpin structure at the end of helix α2p, and of helix α3p facing the PBL. On the 
surface of the cathepsin L propeptide the positive charges are found mainly on the surface of 
helix α3p and the region following C-terminal. The inner surface of these propeptides faces 
the active site cavity and the PBL is more or less neutraly charged due to the hydrophobic 
residues located there. On the surface of the cathepsin L propeptide the positive charges are 
found mainly on the surface of helix  α3p and the region following C-terminal. The inner 
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surface of these propeptides faces the active site cavity and the PBL is more or less neutraly 
charged due to the hydrophobic residues located there. The comparison of the calculated pI´s 
for the mature cathepsin molecules and papain gave a broad range between 4.4 and 8.9 (see 
Table 4-8). Different pIs are even found within the L-type cathepsin subfamily. 
Figure 4-30 (Page 75) The electrostatic surface potentials of cathepsins. 
The propeptides of cathepsins S, K, L, B, and X are shown as Cα traces. All shown molecules 
(PDB entries in brackets) are in the same orientation with view on the active-site cavity and 
the contact area of the mature enzyme and the propeptide. The electrostatic surface potentials 
of the cathepsins were calculated with Swiss-PdbViewer  (Guex & Peitsch, 1997) using the 
atomic  partial  charges  for  each mature  enzyme molecule.  The  colour  of  the  electrostatic 
potential maps ranges from red (-8 kT/mol) via white (neutral) to blue (+8 kT/mol).
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The enzyme domains of cathepsin K, V, S, and papain show a significantly higher pI than 
those of  cathepsins L, B, H, F and X, which predicts larger or more regions of negative 
charges on the molecule surfaces of the latter cathepsins (see Figure 4-30). In contrast to 
cathepsin S, the potentials of cathepsin L, B, and X are negative over extended regions (see 
Figure 4-30). Especially within the active-site cavity and on the surface around this cavity the 
negative  charges  are  concentrated,  whereas  the  electrostatic  potential  map  of  papain  is 
positive, which is also expressed by the pI of 8.88. The molecules of cathepsin K and V show 
an interesting subdivision of the potentials. Around the active-site cavity patches of negative 
potentials  are observed.  However,  the backsides of these molecules show large positively 
charged areas, which explain the calculated pI of 8.92 for K and a pI of 8.59 for V. With the 
exception of cathepsin L, B, and X the active-site cavities and the propeptide-enzyme contact 
areas of the cathepins are more neutrally charged, indicating the hydrophobic nature of the 
propeptide-enzyme domain interactions. With regard to their functional role, the electrostatic 
potentials are discussed below (see Discussion).
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5. Discussion
5.1 Crystallization as implication for an independently folded structure of   
the cathepsin S propeptide
5.1.1 A novel crystallization approach
For the first time, a poorly soluble propeptide of a lysosomal cysteine proteinase has been 
crystallized. Only one other example of a crystallized propeptide had been found earlier, the 
so-called pro-region of  a  bacterial  serine  proteinase called  α-lytic  protease (Sauter  et  al., 
1998). The strategy used for the crystallization of the cathepsin S propeptide consists of the 
combination of a conventional method such as vapor diffusion with the use of a crystallization 
buffer that allows a pH shift from acidic to nearly neutral conditions and leads to folding of 
the cathepsin S propeptides and to the growth of crystals. Figure 5-1 shows the strategy. The 
growth of crystals can be explained in the following way: After equlibration of both buffer 
compounds  within  the  droplet,  formation  of  precipitate  can  be  observed  due  to  the 
aggregation of  partially  or  completely folded  propeptide  molecules.  At  this  stage,  only a 
limited number of folded molecules are solubilized in a folded state. 
Growth of crystals by 
incorporation of folded 
propeptide molecules into 
crystals.
↑
Folded propeptide molecules 
in solution. The number of 
molecules is limited due to 
their poor solubility.
↑
Decrease of precipitate mass 
due to gradual solubilization 
of aggregated molecules
                 Figure 5-1      Crystallization strategy for the cathepsin S propeptide
77
--------------------------------------------------------------------------------------------------------------Discussion
The concentration of the droplet components including the protein, may increases with time 
because  water  diffuses  out  of  the  droplet.  A  possible  transfer  of  isopropanol  from  the 
reservoir  to  the  droplet  may  occur  as  well.  The  folded  propeptide  molecules  begin  to 
aggregate and to order, leading to nucleation of crystals. The growth of crystals depends on a 
pool of folded and solubilized molecules in the droplet. This pool seems to be maintained by 
molecules  dissolved  from the  precipitate,  which  decreases  in  mass  with  time.  A balance 
between solubilized molecules, aggregated molecules in the form of amorphous precipitate, 
and the crystals within the droplet can be assumed. The crystals incorporate folded molecules, 
and  the  molecules  removed  from  the  solution  are  substituted  by  molecules  from  the 
precipitate. This raises the question of how different factors like protein properties, buffer 
compounds, pH, and temperature influence the crystal growth:
• The  protein: The  cathepsin  S  propeptide  is  largely  of  hydrophobic  character.  The 
elevation  of  salt  concentration  or  ionic  strength  resulted  in  no  improvement  of  the 
solubility at neutral pH, at which the propeptide is folded. The solubility of the propeptide 
in an acidic buffer is enhanced in the presence of the solubilizing agent acetonitrile, but the 
protein is not or only partially folded. This way, a high protein concentration could be 
achieved, which is necessary for a successful crystallization in the hanging drop or in the 
capillary (counter diffusion technique). The cathepsin S propeptide folds spontaneously via 
pH shift from acidic to neutral (Maubach  et al., 1997). The folding process is complete 
within one second, as determined by stopped-flow measurements (Schilling et al., 2001). 
• The  crystallization  buffer:  The  only  buffer  to  allow  the  crystallization is  2-(N-
morpholino) ethanesulfonic acid (known as MES), which has a pKa of 6.1. These buffer 
molecules  are  zwitterions  at  low  pH.  For  the  growth  of  diffracting  crystals  a  high 
concentration of MES is necessary. At concentrations below 1 M MES, a high number of 
microcrystals was observed in the droplets. The chance to grow only a few crystals of 
larger size increases with MES concentrations higher than 1 M, and the best results were 
obtained at 1.14 M. The amphoteric character of MES may support the ordering of the 
propeptide molecules in the droplet with time. 
• The organic solvent: Without any organic solvent such as isopropanol, no crystals were 
observed in the droplets. The best diffracting crystals were obtained in the presence of 10% 
isopropanol.  A screen  below 10% yielded  only  microcrystals  within  the  droplets.  The 
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elevation of the isopropanol concentration gave no improvement concerning shape and size 
of the grown crystals. It was also possible to grow crystals in the presence of polyethylene 
glycol, but no improvement of crystal growth could be achieved. More important seems to 
be the concentration of the added organic solvent, which influences the nucleation of the 
crystals.
• pH: The folding of the propeptide is a spontaneous process, which takes place directly 
after the equlibration of the protein solution with the crystallization buffer. The pH of 6.7, 
which was measured after equlibration, is necessary for such a folding process. The use of 
a MES buffer with a pH below 6.75 gave no crystal growth.
• The  temperature: The  velocity  of  crystal  growth  is  determined  by  the  temperature. 
Crystal growth was faster at 30°C than at 20°C. However, even when the temperature was 
elevated to 30°C the crystal growth was a very slow process. Generally, several months 
passed before the crystals reached a suitable size for diffraction measurements. It seems 
that the higher temperature facilitates the folding process, and increases the solubility of 
the  protein,  which  are  the  limiting  factors  in  the  crystallization  of  the  cathepsin  S 
propeptide.
5.1.2 Ostwald ripening
Many small crystals form in a system initially but slowly disappear except for a few that grow 
larger, at the expense of the small crystals. The smaller crystals act as “nutrients” for the 
bigger  crystals.  As the  larger  crystals  grow,  the area  around them is  depleted  of  smaller 
crystals.  This  process  is  termed  “Ostwald  ripening”  (Ostwald,  1896,  1897).  This  is  a 
spontaneous process that occurs because larger crystals are more energetically favoured than 
smaller crystals and is observed in some macromolecular systems (Giegé et al., 1996). While 
the formation of many small crystals is  kinetically favoured, (i.e. they nucleate more easily) 
large crystals are thermodynamically favoured. Thus, from a standpoint of kinetics, it is easier 
to nucleate many small crystals. However, small crystals have a larger surface area to volume 
ratio than large crystals. Molecules on the surface are energetically less stable than the ones 
already well ordered and packed in the interior. Large crystals, with their greater volume to 
surface area ratio, represent a lower energy state. Thus, many small crystals will attain a lower 
energy state if transformed into large crystals and this is what can be observed in Ostwald 
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ripening. This does not happen all the time, and one reason is that the nucleation of many 
small crystals reduces the amount of supersaturation and thus, the thermodynamically favored 
large crystals never get a chance to appear. 
• In the droplets containing the cathepsin S propeptide crystals, a disappearance of small 
crystals followed by growth of larger crystals was never observed. But in all probability, 
the cathepsin S propeptide crystals were grown at the expense of the precipitate observed 
within  the  droplets.  Within  the  droplets  containing  cathepsin  S  propeptide  crystals, 
precipitate  was  observed,  which  appeared  as  crystalline  in  some  cases.  In  this  case, 
Ostwald ripening cannot be excluded because the requirement of crystals grown within the 
precipitate, is given for the growth of crystals at the expense of small crystals, as described 
by Giegé et al. (1996) for other macromolecules. Further experiments are required.
5.1.3 Counter diffusion technique
It is also possible to grow crystals using the counter diffusion approach (Garcia-Ruiz and 
Moreno, 1994), but no improvement concerning crystal size and growth rate was achieved. 
Very little is known about crystallization, the behavior of such poorly soluble proteins and 
about the influence of the chemical and physical parameters on the solubility of the protein. 
Phase diagrams (Miers & Isaac, 1907, Feigelson, 1988) may help to reveal the relationship 
between temperature, precipitant concentration and solubility. Furthermore, the solubility of 
the  cathepsin  S  propeptide  and its  folding  process  might  be  tested  in  MES buffer  using 
spectroscopic methods. The renaturation experiments of denatured cathepsin S in presence of 
its propeptide (Schilling et al. 2001, Pietschmann et al. 2002) could be carried out using MES 
as storing buffer for the propeptide or as renaturation buffer. These kind of experiments may 
help to understand the processes during the crystallization of the cathepsin S propeptide and 
the role of MES. The crystallization method described in this work, might be useful for the 
crystallization of other proteins and peptides of similar solubility properties.
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5.1.4 How is the isolated cathepsin S propeptide structured ?
The successful crystallization of this small protein is a strong argument for an independent 
folding process to ordered structure. The results of the refolding experiments with the wild-
type cathepsin S propeptide (Maubach et al., 1997) and with its mutants (Kreusch et al., 2000, 
Schilling et al., 2001, Pietschmann et al., 2002) point to a tertiary structure, which should be 
similar  to  the  propeptide  part  of  the  determined  procathepsin  S  structure.  With  high 
probability, the crystallized propeptide consists of the globular domain, which contains two 
crossed helices and a third helix behind the hairpin structure. The assumed high number of 
molecules in the asymmetric unit is an indicator for dimer or higher propeptide aggregates in 
the crystal. Further work is required to determine the structure. An optimization of the crystals 
is necessary. Another way to grow crystals of better quality may consists of truncation of the 
propeptide. Especially, the C-terminal part below helix  α3p might be an ideal region for a 
truncation (see Figure 4-16). This part is very flexible and may prevent the improvement of 
the  crystals.  Despite  of  the  low  diffraction  resolution  and  the  poor  quality  of  the  data 
collected,  the  successful  crystallization  is  the  first  step  to  a  prospective  structure 
determination of the cathepsin S propeptide.
5.2 Procathepsin S structure and the functional role of the propeptide
5.2.1 Cathepsin S-specific interactions between the propeptide and the enzyme
The structure of human procathepsin S is quite similar to the structures of the previously 
solved L-like proenzymes. Nevertheless, some striking features are found. The cathepsin S-
specific orientation of helix  α3p in the propeptide is the result of an interaction between 
Met83p of the loop region between helix 3101p and helix  α3p and Phe146 of the PBL. The 
cathepsin S-specific residues Phe146 and Arg141 are mentioned in the previously determined 
structures of mature cathepsin S (McGrath  et al.  1998; Turkenburg  et al.  2002), but their 
functional  role  could not  be  clarified because the enzymes were crystallized without  any 
peptides as possible interacting partner. In the structure of human procathepsin S cathepsin S-
specific  interactions  in  form  of  a  C-H⋅⋅⋅pi bond between  Phe146  and  a  residue  of  the 
propeptide can be observed. Furthermore, an interesting C-H⋅⋅⋅pi bond can be seen in the C-
terminal part below the S3 pocket between Phe70 and Pro98p (see Figures 4-27 and 4-28). As 
found for Phe146, the aromatic ring of Phe70 is flipped towards the propeptide, whereas the 
81
--------------------------------------------------------------------------------------------------------------Discussion
same residues in the determined mature cathepsin S structure are directed away from the 
enzyme towards the solvent. Only in procathepsin K, a similar interaction was found. The 
superposition of all determined cathepsin K-inhibitor complexes with cathepsin S and their 
proenzymes revealed that the corresponding Tyr67 shows the same orientation as Phe70 in 
mature cathepsin S. In contrast to the mature enzyme, in procathepsin K the aromatic ring of 
Tyr67 is also flipped towards a proline (Pro81p) of the C-terminal part of the propeptide (see 
Figure 5-2).  Between Pro81p and Tyr67, a similar  C-H⋅⋅⋅pi bond could be identified.  The 
consequences  of  such interactions,  which result  in  a  different  propeptide orientation with 
respect to the enzyme surface are discussed below in context to the functional of role of the 
propeptide.
5.2.2 Inhibition by the propeptide and selectivity
Many investigations were focused on the design of highly potent and selective proteinase 
inhibitors but up to now the selective inhibition of a proteinase is an unsolved challenge. In 
recent years, attention was directed to the inhibitory properties of propeptides of papain-like 
proteinases, especially of the L-type cathepsins. The high structural homology and the same 
mode of binding of the propeptides on the enzyme surface make this subfamily interesting for 
seeking  selective  differences.  The  precondition  for  a  successful  inhibition  consists  of  a 
complex  formation  of  the  propeptide  and  the  cognate  enzyme,  which  is  strongly  pH-
dependent,  correlating  with  significant  pH-dependent  changes  of  the  propeptide  structure 
(Maubach et al. 1997, Jerala et al., 1998). The N-terminal globular domain of the propeptides 
is folded at physiological pH conditions. A pH shift to acidic conditions may lead to a break 
of  stabilizing  salt  bridges  and  hydrophobic  interactions  within  the  propeptides,  which  is 
concomitant with a breakdown of the tertiary structure and the loss of the inhibitory capacity. 
The majority of structured determinants for recognition of the cognate enzyme surface are 
located  in  the  globular  domain  of  the  propeptide.  Previous  in  vitro experiments  on  the 
inhibitory specificity of the propeptides towards different members of the cathepsins revealed 
that the cathepsin S propeptide inhibits cathepsin L as much as its cognate enzyme cathepsin 
S. However, the inhibition of cathepsin S by the cathepsin L propeptide was only very weak 
(Maubach et al. 1997; Guay et al. 2000; Guo et al. 2000), which could recently be confirmed 
by Anne Schlabrakowski (personal communication by K. Schilling). In an initial study the 
cathepsin L propeptide gave a significant higher Ki for Cathepsin S (22.04 ± 0.43 nM) than 
for  cathepsin  L  (0.082  ± 0.004  nM)  and  cathepsin  K  (1.74  ± 1.32  nM).  However,  no 
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significant differences of the Ki values were found for the inhibition of cathepsin K by the 
cathepsin S propeptide and the inhibition of cathepsin S by the cathepsin K propeptide.
5.2.2.1 The functional role of Arg141 and Phe146 in cathepsin S 
The  comparison  of  the  L,  K  and  S  propeptide  structures  shows,  that  the  cathepsin  L 
propeptide contains two phenylalanines (Phe63p and Phe71p). Phe63p of the loop between 
strand  β1p and helix α3p, and Phe71p of helix α3p extend into the vicinity of the active site 
(Figure 4-26). These two phenylalanines make hydrophobic contacts to Leu144 of the PBL. 
In  cathepsin S,  Leu144 is  replaced by  Phe146.  A complex  between cathepsin  S and the 
cathepsin L propeptide may lead to sterical clashes between the three phenylalanines. The 
side chains of Leu80p and Val91p of the cathepsin S propeptide point in the same direction as 
the equivalent residues Phe63p and Phe71p of the cathepsin L propeptide. On the other hand, 
the short  residues of the helix  α3p of the cathepsin S propeptide may allow an effective 
binding  onto  the  surface  of  the  cathepsin  L  active  site  without  sterical  clashes.  In  the 
propeptide of cathepsin K, Phe63p is also replaced by a leucine, namely Leu63p, and helix α
3p contains short residues extending into the S´-groove, as well. This may guarantee a good 
inhibition of cathepsin L and S, resulting in the similar inhibition constants. The orientation of 
Phe146 in the procathepsin S structure indicates a potential involvement in the formation of 
the  S´1  substrate-binding  site.  Crystallization  of  the  enzyme  in  complex  with  different 
substrates may elucidate this.
Another cathepsin S - specific residue in the PBL is Arg141, which may play a key role in the 
different inhibitory behavior of the propeptides.  In the previously determined cathepsin S 
structures the side chain of Arg141 is directed away from the active site to the solvent. The 
high averaged B-factor of 58.0 Å2 for the side chain and the poorly defined electron density 
indicate a flexible side chain,  which may adopt  different conformations and interact with 
possible  substrates  (McGrath  et  al.  1998;  Turkenburg  et  al.  2002).  From  helix  α3p  of 
cathepsin S Thr92p points towards Arg141 forming a possible van der Waals contact with the 
hydrophobic part of the arginine side chain (Figure 4-26 and 4-27). In the corresponding helix 
of the cathepsin L propeptide, Arg72p occupies the position of Thr92p (Figure 4-27). In the 
complex  between the  cathepsin  L  propeptide  and cathepsin  S,  there  may be  a  repulsion 
between  the  long  and  positively  charged  residues.  Between  Thr92p  of  the  cathepsin  S 
propeptide  helix  and  the  PBL  residue  Gly139  in  cathepsin  L,  likewise  repulsion  is  not 
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expected.  Consequently,  Phe146  and  Arg141  may  play  a  key  role  in  the  specificity  of 
inhibitory propeptides and designed inhibitors, which could be proven by mutation of Phe146 
and Arg141. The different Ki values determined for the cathepsin L propeptide with respect to 
cathepsin  L  and  K  could  be  explained  by  a  possible  sterical  hindrance  between  the 
phenylalanines 63p and 71p and Gln143 of the PBL of cathepsin K, which may lead to a 
weaker inhibition of cathepsin K in comparison with L. 
Furthermore,  Arg141  is  discussed  as  a  critical  residue,  which  prevents  the  inhibition  of 
cathepsin S by the MHC class II-associated p41 li  fragment  (Guncar  et al.,  1999).  After 
cleavage  of  p41 by  cathepsin  L  or  S,  the  fragment  inhibits  cathepsin  L.  In  this  way an 
enhancement of ther antigen presentation by inhibiton of the destructive cathepsin L activity 
is  assumed (Rodriguez  & Diment,  1995).  The  p41 fragment  does  not  inhibit  the  closely 
related cathepsin S, which is explained in a modeled cathepsin S structure by sterical clashes 
between  Arg141  with  p41  residues  and  unfavourable  electrostatic  interactions  between 
positively charged residues of p41 and the positively charged Arg141 (Guncar et al., 1999). In 
cathepsin L, Arg141 is replaced by Gly139, wich allows, in connection with neighbouring 
hydrophobic as well as negatively charged residues, the occupation of the active site by p41.
5.2.2.2  Inhibitory activity by the C-terminal part of the propeptide
Inhibition studies with truncated cathepsin L propeptides towards cathepsin L revealed that 
the  C-terminal  region  contributes  little  to  the  overall  inhibition  (Carmona  et  al.,  1996). 
However,  similar  investigations  on the  inhibitory activity  of  cathepsin B propeptide with 
mutated  amino-acid  residues revealed  that  the  C-terminal  part  containing  the  residues 
occupying the S pockets is essential for the inhibitory activity of the cathepsin B propeptide 
(Chen et al.,1996). But concerning selectivity no exact data are presently available about the 
complete  C-terminal  part  of  the  cathepsin  propeptides.  The  C-terminal  part  between  the 
residues  occupying  the  S-  subsites  and  the  connection  to  the  enzyme  domain  is  highly 
flexible, and up to now no implications were found for a role in the specificity of inhibition. 
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The C-terminal part of the cathepsin propeptides can be subdivided into two parts: 
1. Amino acid residues, that occupy the S pockets:
The S1 and S2 pockets of the L-like cathepsins are occupied by short residues, whereas large 
residues such as arginine, lysine or glutamine are sticking into the S3 pocket. The pictures of 
Figure 5-2 display the residues of the C-terminal propeptide part, which are located in the 
substrate-binding  sites.  In  order  to  visualize  the  substrate-binding  sites,  the  inhibitor 
APC3328  (vinyl-sulfone-inhibitor,  PDB  entry  1MEM)  was  modelled  into  the  active-site 
cavities of the cathepsins S and L using the crystal structure of cathepsin K with this inhibitor 
as  a  template  (McGrath  et  al.,  1997).  The  modelling  of  this  inhibitor  was  based  on  the 
assumption that its orientation would be nearly the same in the active-site cavities of all L-like 
cathepsins.  In  cathepsin  S,  Phe70  seems  to  determine  the  anchoring  of  the  C-terminal 
propeptide part via a C-H⋅⋅⋅pi bond to Pro98p (Figure 4-28 and 5-2), and the same interaction 
between an aromatic residue (Tyr67) and a proline (Pro81p) can be observed in procathepsin 
K (Pro81pCDΕΕΕTyr73pi distance = 3.34 Å and ρ Pro81pCDH – Tyr73pix = 131.69°). Lecaille et 
al. (2002) replaced Tyr67 and the C-terminal residue Leu209, which border the S2 pocket, by 
leucine and alanine, respectively. The introduction of the double mutation into the S2 subsite 
of cathepsin K changed the unique S2 binding preference of the protease for proline and 
leucine  into  a  cathepsin  L-like  preference  for  phenylalanine.  The  cathepsin  L-like  S2 
specificity of the mutated proteinase and the integrity of its catalytic site were confirmed by 
kinetic  analysis  of  synthetic  di-  and  tripeptide  substrates  as  well  as  pH stability  and  pH 
activity profile studies. The loss of the ability to accept proline in the S2 binding pocket by 
the mutated proteinase completely abolished collagenolytic activity of cathepsin K. These 
results indicate that Tyr67 and Leu209 play a key role in the binding of proline residues in the 
S2 pocket of cathepsin K and are required for its collagenase activity. In the procathepsin S 
structure, Phe70 and Phe211 are arranged similarly as Tyr67 and Leu209 in cathepsin K and 
aromatic residues of Tyr67 and Phe70 interact in a similar way with prolines coming from the 
equivalent location of the propeptide region (see Figure 5-2). As described for cathepsin K, 
cathepsin S shows collagenolytic activity as well (Kirschke  et al., 1989). The S2 pocket of 
cathepsin L is occupied by a phenylalanine (Phe78p). The preference of less bulky residues in 
the P2 position for cathepsins S and K may explain the weaker inhibition of the two enzymes 
by the cathepsin L propeptide. 
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2. Residues forming a loop surrounding the bottom side of the enzyme surface and connecting 
covalently the propeptide with the enzyme domain:
In  the  C-terminal  part,  below  the  residues  occupying  the  S  pockets  of  the  cathepsin  L 
propeptide, large residues such as Asn80p, Arg81p, Lys82p, and Arg84p are found instead of 
the anchoring prolines of the cathepsin S and K propeptides (see Table 5-1 and Figure 5-2). 
These residues  may prevent  a  closeness  of  the C-terminal  propeptide part  to  the enzyme 
surface due to possible sterical clashes (see Figures 4-17 and 5-2). This region has a positively 
charged  electrostatic  potential  (see  Figure  4-29),  and  a  repulsion  with  positively  charged 
residues of  the cathepsin S and K enzymes could lead to  an inefficient  inhibition by the 
cathepsin  L  propeptide.  But  it  is  difficult  to  identify  residues  of  the  cathepsin  K  and  S 
enzymes  that  may  interact  with  residues  from  the  C-terminal  part  of  the  cathepsin  L 
propeptide. A superposition of all cathepsin L-like propeptides on different mature cathepsin 
enzymes gave differences between the compared C-terminal parts of the propeptides. Beyond 
the S3 subsite, the propeptide of cathepsin K forms a loop or, in the cathepsin S propeptide, a 
type  III  β-turn  (see  also  Table  5-1).  The  positively  charged  residues  in  this  region  of 
procathepsin L interact with the residues of the enzyme domains through hydrogen bonds and 
salt  bridges.  These  aspects  raise  the  question  in  how  the  second  part  of  the  C-terminal 
propeptide region is involved in the inhibition of cathepsin-like proenzymes. The results of 
the investigations in recent years exclude an inhibitory capacity of the flexible C-terminal 
propeptide parts connecting the propeptide with the enzyme domains. But all these studies 
were carried out with expressed or chemically synthesized propeptides. The C-terminal parts 
of these structural elements used in the experiments are not covalently bound to the enzyme 
domains. Further investigations are required to elucidate the influence of these propeptide 
parts  on  inhibition.  One  step  into  this  direction  are  studies  with  synthetic  peptides 
(Chowdhury et al., 2002) and endogenous cysteine proteinase inhibitors of different species 
(Yamamoto et al., 2002), which show a high homology to the cathepsin propeptides.
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Legend to Figure 5-2 (page 87)
The propeptide regions of cathepsin S (Image A), K (Image B), and L (Image C) are shown as 
ball-and-sticks-models in the substrate-binding sites of their cognate enzymes. The atoms are 
coloured in blue (N), red (O), yellow (S), and white (C). All molecules (PDB entry 1BY8 for 
procathepsin K, 1CS8 for procathepsin L) are in the same orientation with view on the active-
site  cavity.  The  inhibitor  APC3328  (green)  was  modelled  into  the  active  sites  by 
superposition of the cathepsin K-inhibitor complex (PDB entry 1MEM) with procathepsin S, 
K, L. The electrostatic potentials on the surface (transparent) of the enzyme domains of the 
procathepsins were calculated with the Swiss-PdbViewer (Guex & Peitsch, 1997) using the 
atomic partial  charges  for  each  mature  enzyme molecule.  The  colour  of  the  electrostatic 
potential maps range from red (-8 kT/mol) via white (neutral) to blue (+8 kT/mol).
S K L   Table 5-1 Propeptide residues of the C-terminal part
Ser94p
Leu95p
Arg96p
Val97p
Pro98p
Ser99p
Gln100p
Trp101p
Gln102p
Arg103p
Gly77p
Leu78p
Lys79p
Val80p
Pro81p
Leu82p
Ser83p
His84p
Ser85p
Arg86p
Gly77p
Phe78p
Gln79p
Asn80p
Arg81p
Lys81p
Pro83p
Arg84p
Lys85p
Gly86p
S 1
S 2
S 3
   S1-3: Substrate binding sites.
   Positively charged residues are highlighted in blue,
   residues involved in a loop (cathepsin K) or in a
   type III β-turn (cathepsin S) in green.
   
5.2.3   Consequences for the cathepsin S propeptide structure after mutation of
           conserved residues of the ER(F/W)N(I/V)N-motif 
The procathepsin S structure allows the localization of conserved residues in the globular 
domain of the propeptide. Some of these residues were exchanged by alanines (Kreusch et al., 
2000), and the mutated propeptides analyzed with respect to folding competence, inhibitory 
capacity and their ability to fold independently to a tertiary structure (Schilling et al., 2001, 
Pietschmann  et  al.,  2002).  These  investigations  have  been  described  in  the  introduction. 
Considering the positions of the mutated tryptophanes 28, 31, and 52 in the globular domain, 
it can be assumed that lack of one of these residues may prevent an interaction between the 
crossed helices α1p and α2 (see Figure 4-24). The loss of inhibitory and folding properties of 
the tryptophane mutants is  coupled with a  loss of  the tertiary structure,  which cannot  be 
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completely compensated by salt bridges and hydrogen bonds formed by conserved amino-
acids within the propeptide. 
Apart  from the tryptophanes, only a substitution of the conserved Val59p and Asn63p by 
alanines led to a significant decrease of folding competence and inhibitory capacity towards 
cathepsin S (Val59p: Ki 1.27 nM; Asn65p: Ki 1.85 nM; wildtype: Ki 0.06 nM; Schilling et al. 
2001, Pietschmann et al., 2002). In comparison to the wild-type propeptide, only a minor red-
shift  of  the  fluorescence  emission  spectra  was  found  for  the  in-vitro folded  mutants 
Val59pAla  and  Asn63pAla,  indicating  a  folded  structure  similar  to  that  of  the  wildtype 
propeptide.  The  same  mutations  in  the  zymogen  did  not  affected  transport  through  the 
transfected cells as well  as maturation and secretion of the proenzyme (Kreusch et al., 2000). 
The hydrogen bonds between Asn63p and the main-chain atoms of Leu75p contribute to the 
stabilization of the helix-loop-sheet structure near the end of helix α2p, where a hydrophobic 
interface to the PBL is formed. This hydrophobic interface displays the upper side of a contact 
area  with  the  prosegment-binding  loop  (PBL)  (Figure  4-24)  and  represents  an  important 
propeptide-enzyme interaction site. Alterations in this region may influence the orientation of 
the propeptide to the substrate-binding site and may prevent an optimal folding process and an 
inhibition of cathepsin S by its propeptide. The replacement of  Asn63p by alanine may lead 
to a loosening of the loop-hairpin-loop-helix α2p interaction. Val59p forms a van der Waals 
contact to the hydrophobic side chain of Leu147 of the PBL (Figure 4-24 and 4-25). The lack 
of the Val59 side chain may lead to a possible reduction of the hydrophobic contact area to 
the PBL resulting in an altered position of the propeptide towards the surface of cathepsin S. 
The exchange of Glu87p by an alanine had no significant consequences. The conserved salt 
bridge (Figure 4-24) between Glu87p (α3p) and Arg48p (α2p) anchors the third propeptide 
α-helix onto the second one, but it does not seem to be necessary for the propeptide to cover 
effectively the active site. 
The functional role of the conserved  ER(F/W)N(I/V)N-motif is unclear. With respect to all 
mutated  residues  of  the  propeptide  region,  only  four  residues  (Trp28p,  Trp31p,  Trp52p, 
Asn63p)  are  critically  involved  in  the  formation  of  the  tertiary  propeptide  structure,  and 
Val59p is involved in the anchoring of the propeptide onto the PBL. Only three of these 
residues, namely Trp52p, Val59p and Asn63p belong to the conserved motif. Several other 
residues are involved in the stabilization of the N-terminal globular domain of the propeptide, 
and are also involved in the interaction between propeptides and their cognate enzymes (see 
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also Table 4-7). It cannot be excluded that the mutation of other non-conserved residues may 
have more dramatical  effects  on the propeptide structure than observed so far.  The most 
important  aspect  is  the  formation  of  the  hydrophobic  core  by  three  interdigitating 
tryptophanes coming from the two crossed helices in the N-terminal region of the cathepsin 
L-like cathepsins. This, and the formation of the helix-loop-sheet structural motif mentioned 
above, are the most important parts of the propeptide structure, which determine the folding 
and the inhibition of the cathepsin L-like proteinases. 
5.2.4   Electrostatic potentials and their influence on the activity of cathepsins 
Cathepsin S is proteolytically active at a broad pH range (pH 4.5-7.5) against substrates such 
as collagen and elastin (Kirschke et al., 1989, Brömme et al., 1993). At pH 7.5 cathepsin S 
shows  a  stable  catalytic  activity  against  synthetic  substrates  for  at  maximum  15  hours, 
whereas  similar  studies  on cathepsin K (Brömme  et  al.,  2000),  L,  V (Turk  et  al.,  1993, 
Brömme et al., 1999) and B (Turk et al., 1994) gave a complete inactivation after 6 minutes 
(cathepsin K, substrate: collagen), 1 hour (cathepsin V), 15-20 minutes (cathepsin L), and 11 
minutes (cathepsin B) at pH 7.0-7.5. The unusual stability of cathepsin S at neutral pH could 
be explained by the electrostatic potential on the surface of cathepsin S, which is, in contrast 
to the other cathepsins, more neutral (see Figure 4-30). Especially in the region of the active 
site cavity and nearby, the molecule is more or less uncharged (pI see Table 4-8), whereas the 
same  region  in  cathepsin  L  and  B  has  a  strong  negative  electrostatic  surface  potential. 
However, in the same region cathepsin K and V show some negative patches. Papain exhibits 
the greatest stability with 40 hours at pH 8.5 (Skelton, 1968, Groeger  et al., 1989) and the 
highest pI (see Table 4-8) in comparison with the cathepsins mentioned above. On the surface 
of papain an equal distribution of neutral and positive patches is observed (see Figure 4-30). 
The neutral and positive electrostatic potentials in the area around the active site cavity may 
contribute to the stability of papain and cathepsin S, because at neutral/alkaline pH there are 
no repulsion effects between hydrophobic and basic amino acid residues in the region of the 
active site cavity which may lead to destructive alterations of the enzyme domains. In the 
same region of cathepsin L, B, K, and V, alkaline pH conditions may lead to repulsion effects 
between the negatively charged residues resulting in the observed inactivation of the enzymes 
but  data  about  possible  alterations  in  their  structures  are  not  published.  However,  the 
destructive  influence  of  low  pH  on  the  tertiary  structure  combined  with  an  irreversible 
inactivation of the enzyme was shown for cathepsin L by circular dichroism spectroscopy 
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(Turk et al., 1999). The measurements resulted in a decrease of the helical content at pH 3.0 
and 4.0, which is in agreement with an acid-denatured protein described by Tanford  et al. 
(1968).
Another  aspect  consists  of  the observation that  the collagenolytic  activity  of  cathepsin K 
increases in the presence of chondroitin-4-sulfate (Li  et al., 2000). Based on the fact, that 
cathepsin K plays a predominant role in the osteoclastic matrix degradation the influence of 
glycosaminoglycans  on  the  activity  of  cathepsin  K  was  studied.  In  the  presence  of 
chondroitin-4-sulfate the residual activity of cathepsin K increased about 5-10-fold over a pH 
range of 5.5 to 7.5. Furthermore, its half-life increased at pH 7.0 from 6 to 40 minutes, which 
was interpreted as an increase of the intrinsic stability of cathepsin K. The same experiments 
carried out with cathepsin L gave no increasing of its half-life, the enzyme was completely 
inactivated  above  pH  6.5.  The  increased  stability  of  cathepsin  K  in  the  presence  of 
chondroitin-4-sulfate  is  interpretated  as  an  interaction  between  the  negatively  charged 
glycosaminoglycans and the positively charged surface area on the backside of cathepsin K, 
which results in a structure stabilization. Such interactions can be excluded for cathepsin L 
due  to  the  strong  negative  electrostatic  potential  on  the  surface  of  the  enzyme.  Further 
investigations concerning the interactions of substrates and parts of cellular components with 
cathepsins  via  their  surface area potential  are  necessary for  a  better  understanding of the 
influence of such compounds on the activity of lysosomal proteinases.
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